Methods for identifying subject emotions from saliva samples
By calculating the ratios of α-amylase, cortisol, dehydroepiandrosterone and its derivatives, and oxytocin in saliva samples, the problem of unstable distribution of biomarkers in saliva in existing technologies has been solved, and a method for accurately identifying and predicting the emotional state of subjects after olfactory stimulation has been realized.
Patent Information
- Application Number
- CN202480086755.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2023-12-28
- Filing Date
- 2024-12-30
- Publication Date
- 2026-11-17
AI Technical Summary
There is a lack of reliable and easy-to-implement biological testing methods in the current technology for identifying an individual's emotional state through saliva samples. In particular, the distribution of biomarkers in saliva after olfactory stimulation is affected by factors such as circadian rhythm, physiological state and food intake, which leads to bias in the test results.
By calculating the amount and concentration ratio of specific biomarkers in saliva samples before and after olfactory stimulation, the ratios of α-amylase, cortisol, dehydroepiandrosterone and its derivatives, and oxytocin in saliva are identified, and bioanalytical characteristics are established to distinguish and identify the emotional groups felt by the subjects.
It enables reliable identification and prediction of the emotional state of subjects from saliva samples after olfactory stimulation, and allows selection of group members or potential customers suitable for specific olfactory stimuli, improving the accuracy and reliability of the test.
Smart Images

Figure FT_1 
Figure FT_2 
Figure FT_3
Abstract
Description
[0001] This invention relates to a method for identifying, from a subject's saliva sample, an emotion or group of emotions felt in response to olfactory stimulation using salivary biomarker characteristics. In a second aspect, the invention also relates to a method for assessing the ability of olfactory stimulation to evoke a desired emotion or group of emotions in a subject. Finally, the invention relates to the use of a reagent kit within the context of this invention.
[0002] Recent research has shown that emotional states (positive and negative) can be distinguished by physiological responses. This physiological regulation is achieved through the action of biomolecules, such as enzymes and hormones, which are present not only in regular biological fluids but also in saliva. The levels of these molecules represent the activity of the autonomic nervous system (SN), including the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
[0003] Among the biomolecules or biomarkers (BMs) present in saliva that can be used to distinguish such emotional states, some known emotion-related biomarkers can be listed. These biomarkers can be used to identify and predict emotions triggered by various stimuli (see [link to relevant documentation]). Figure 1 ):
[0004] Phenylalanine, tyrosine, tryptophan, levodopa, dopamine, norepinephrine, adrenaline, acetylcholine, cortisol, oxytocin, 5-HT, melatonin, substance P, chromogranin A, DHEA, DHEA sulfate, ghrelin precursor, α-amylase, BDNF, NPY and peptide YY, prostaglandins, endorphins, immunoglobulin A.
[0005] Currently, although some methods have been published, especially those based on blood samples, there is no reliable or effective biological test. Ideally, a low-cost and easy-to-implement biological test should be used to provide physiological data on an individual's emotional state.
[0006] While not limited to these specific molecules present in saliva, the inventors have identified four biomarkers (BMs) among a large number of biomarkers present in saliva, and the combination of these four biomarkers alone can provide such data. The salivary biomarkers identified by the inventors are as follows:
[0007] -Alpha-amylase (α-amylase; AA)
[0008] - Cortisol
[0009] -Dehydroepiandrosterone (DHEA) and its known derivatives in the human body (such as its sulfated ester (DHEA sulfate, or SDHEA for short)); and
[0010] -Oxytocin (OXT).
[0011] However, the inventors have clearly demonstrated that circadian rhythms, the physiological state of the test subject, stress, food intake, etc., strongly influence the distribution levels of the basic biomarkers under study in saliva, making it difficult or even impossible to measure the effect of olfactory stimulation on the salivary biochemical markers collected after stimulation using reliable or effective biological tests (see, for example...). Figure 6 and Figure 7 Drastic changes throughout the day may bias the results of MB measurements during olfactory stimulation studies.
[0012] Surprisingly, by calculating the ratio of the amount and / or concentration of each of the BMs present in the saliva samples before and after olfactory stimulation, the inventors have demonstrated that specific bioanalytical features (also referred to herein as patterns, profiles, or algorithms based on specific biomarkers) can be established from the saliva samples of subjects to distinguish / identify the emotions or groups of emotions felt by the subjects as evoked by the stimulation.
[0013] Given that these BM ratios actually need to be calculated, the inventors have demonstrated that it is possible to identify profiles of people who produce stronger or weaker biological responses to olfactory stimuli.
[0014] According to the present invention, and in another aspect, the inventors have also demonstrated that group members or potential customers suitable for a specific olfactory stimulus (such as perfume / fragrance) can be selected based on measurements of these four BM ratios and their specific combinations from saliva samples.
[0015] In the first step, the inventors specifically confirmed the presence of these four biomarkers in saliva and verified the measurement quality of the selected four biomarkers in saliva in the first cohort of subjects. Then, in the second step, specific biomarkers were searched through different methodological approaches, particularly by using other cohorts of subjects and based on standard statistical methods well known to those skilled in the art.
[0016] In a first aspect, the present invention relates to a method for measuring the amount and / or concentration of salivary biomarkers (BMs) in a subject stimulated by an olfactory stimulus, wherein the salivary BMs are selected from the group consisting of:
[0017] - Phenylalanine, tyrosine, tryptophan, levodopa, dopamine, norepinephrine, epinephrine, acetylcholine, cortisol, oxytocin, 5-HT, melatonin, substance P, chromogranin A, DHEA, DHEA sulfate, ghrelin precursor, α-amylase, BDNF, NPY and peptide YY, prostaglandins, endorphins and immunoglobulins, and wherein the method comprises the following steps:
[0018] 1) Collect the subject’s first saliva sample (referred to as SI) prior to the stimulation;
[0019] 2) Stimulate the subject with the olfactory stimulus;
[0020] 3) Collect at least a second saliva sample (referred to as S2);
[0021] 4) Measure the amount and / or concentration of each of the BMs present in the SI and S2 saliva samples;
[0022] 5) Calculate the BM ratio (referred to as S2 / S1) for each selected BM.
[0023] In a preferred embodiment of the method of the present invention, the selected BMs have been reliably measured previously in a statistically significant group of saliva samples obtained using different and unique fragrances or fragrance combinations to check whether no correlation or weak correlation is observed among the selected BMs.
[0024] This can be achieved, for example but not limited to, through analysis of covariance or through statistical methods well known to those skilled in the art (see [link to relevant documentation]). Figure 10 A to Figure 10 B and Example 8 Figure 17 (Legend of the diagram)
[0025] In a preferred embodiment of the method of the present invention, the amount and / or concentration of each of the following BMs is measured at step 4): α-amylase, cortisol, dehydroepiandrosterone (DHEA), and oxytocin.
[0026] More preferably, the method of the present invention involves collecting saliva samples S1 and S2 at any time of day, preferably in the morning, and more preferably between 9:00 a.m. and 12:00 p.m.
[0027] It is also preferred that the time interval (elapsed time) between the collection of SI and S2 saliva samples is <60 minutes, preferably ≤30 minutes or ≤20 minutes.
[0028] See, for example Figure 9 Where T1 = 5 minutes before stimulation and T2 = 5 minutes after stimulation.
[0029] In a specific embodiment of the method of the present invention, a third saliva sample, S3, is collected after S2 at any time of day, preferably in the morning between 9:00 a.m. and 12:00 p.m., based on the emotions felt by the subject after being stimulated, and wherein the BM ratio (referred to as S3 / S1) of each of the selected BMs is also calculated.
[0030] See, for example Figure 9Where T1 = 5 minutes before stimulation, T2 = 5 minutes after stimulation, and T3 = 20 minutes after stimulation.
[0031] In another specific embodiment of the method according to the invention, saliva samples collected in steps 1 and 3 before and / or after stimulation, which are freshly collected or stored at different temperatures (e.g., at room temperature (RT), +4°C, or -20°C), are used to measure the amount and / or concentration of each of the BMs present in the saliva samples.
[0032] (See) Figure 3 The figure shows the time period during which saliva samples can be stored for at least 7 days.
[0033] In another preferred embodiment of the method according to the invention, the ratio value S2 / S1 calculated for each BM in step 4) is a continuous variable or a discretized variable, preferably a discretized variable.
[0034] The term "discretization" means that the variable is a variable that takes different, countable values. (See example) Figure 31 The BM ratio is discretized into three categories (i.e., <0.9 = decreasing; ≥0.9≤1.1 = stable; and >1.1 = increasing).
[0035] A continuous variable is a variable that can take any value within a certain range, and the number of possible values within that range is infinite.
[0036] In a second aspect, the present invention relates to a method for determining salivary BM characteristics in relation to said subject and a given olfactory stimulus from a saliva sample of a given subject, wherein the method comprises the following steps:
[0037] A) By means of the method according to any one of claims 1 to 4 of the present invention, measuring and calculating the BM ratio S2 / S1 for each of the selected BMs, step A) ultimately determines the profile of these four BMs associated with the stimulus and the subject; and
[0038] B) Based on the results obtained in step A), determine the salivary BM characteristics associated with the stimulus and the subject.
[0039] In a preferred embodiment, in step B), the emotional response felt by the subject is discretized for a specific emotion or fragrance, preferably, the participant’s response to each emotion or fragrance is discretized according to, for example but not limited to, “true” and “false” or equivalent terms (i.e., positive and negative; 1 (positive) and 0 (negative)).
[0040] For example, but not limited to, for emotional responses, the responses are “discretized” into two categories, such as:
[0041] - Negative reaction, corresponding to a reaction that evokes no emotion or feeling of any emotion towards the fragrance, and
[0042] - Positive responses, grouping reactions to strong to moderate sensations of the fragrance together.
[0043] (See Example 7, Group Study).
[0044] In this specification, the terms “reference feature”, “reference saliva feature”, “reference BM pattern”, “reference saliva BM pattern”, “reference profile” and “reference saliva profile” have the same meaning and can be used interchangeably.
[0045] In a third aspect, the present invention relates to a method for identifying / determining reference features associated with an emotion / emotional response and / or emotion group and / or fragrance and / or fragrance group felt by the subject after the subject has been subjected to olfactory stimulation, the method comprising the following steps:
[0046] C) Measure and calculate the BM ratio S2 / S1 for each selected BM by the method according to the invention;
[0047] D) Repeat step C) for all subjects / individuals in a statistically significant cohort / group, using the same stimulus, and identify / determine the reference features associated with the said emotion and / or emotion group and / or fragrance and / or fragrance group using standard statistical methods.
[0048] In a preferred embodiment, step D) is performed on the different groups obtained after the queue / group is divided using a standard partitioning statistical method, thereby allowing the identification or determination of reference characteristics of each of these different groups, preferably using k-means or hk-means (stratified k-means) statistical classification methods.
[0049] These standard statistical methods are well known to those skilled in the art (see, but not limited to, the statistical methods cited and used in the relevant embodiments).
[0050] In a preferred embodiment, in step B), the standard statistical method for the partitioning is allowed to be selected from one or a combination of the following methods: principal component analysis (PCA), k-means, hk-means (stratified k-means), and CART method (“classification and regression tree” method).
[0051] It is also preferred to use the method according to the invention, wherein the individual measurement of the BM ratio is performed simultaneously with a questionnaire on the emotions felt by the subject after the olfactory stimulation.
[0052] For the general concept of the invention and in a preferred embodiment, the emotions / emotional responses and / or mood groups and / or fragrances associated with the saliva characteristics felt by the subject after olfactory stimulation and the need to identify / determine reference saliva features: saliva BM pattern / reference profile and / or fragrance groups and / or moods / emotional responses and / or fragrance groups may include, but are not limited to, the following emotions or fragrances: indulgence, elegance, confidence, happiness, vitality, uniqueness, sensuality, comfort, relaxation, or combinations thereof.
[0053] In a preferred embodiment, the method of the present invention includes a latent test on a statistically significant cohort of subjects who smell the same fragrance or fragrance group used to develop the biomarker-based emotional profile.
[0054] In a preferred embodiment, step B) of the method of the present invention includes the step of dividing or clustering cohort / group participants into different groups and nesting them together using standard statistical analysis methods well known to those skilled in the art, such as, but not limited to, k-means and / or stratified k-means (hk-means) methods, based on ratio profiles or characteristics of salivary biomarkers.
[0055] See Figure 20A to Figure 20D , Figure 21 , Figure 22A to Figure 22F and Figure 23 Legend of the diagram.
[0056] In a fourth aspect, the present invention relates to a method for predicting, identifying, or classifying, from a saliva sample from a subject, an emotion or group of emotions felt by the subject after being stimulated by an olfactory stimulus, the method comprising the following steps:
[0057] E) By means of the method according to any one of claims 1 to 5 of the present invention, the BM ratio S2 / S1 of each selected BM in the saliva sample of the subject is measured and calculated, and the salivary BM characteristics of the four BMs under the stimulation are finally determined.
[0058] F) Compare the saliva features obtained in step E) with reference saliva features obtained for these four BMs, the reference saliva features being identified as being associated with emotions or emotion groups; and
[0059] G) Based on this comparison, predict, identify, or classify the emotion or group of emotions felt by the subject after being stimulated by the olfactory stimulus.
[0060] In a fifth aspect, the present invention relates to a method for determining the ability of olfactory stimulation to evoke / remove a desired emotion or group of emotions in a subject from a saliva sample, the method comprising the steps of:
[0061] H) By measuring and calculating the BM ratio S2 / S1 for each selected BM according to the method of the present invention, the salivary BM characteristics associated with the stimulus are finally determined;
[0062] I) Identify reference saliva BM features associated with the emotion or emotion group expected to be evoked / elicited after olfactory stimulation, said reference features being obtained by the method according to claim 6 of the invention.
[0063] J) Compare the saliva BM features obtained in step H) with the reference BM features identified in step I); and
[0064] K) Based on this comparison, determine whether the stimulus of the test can evoke / elicit the desired emotion or emotion group.
[0065] On the other hand, the present invention relates to the use of at least one, two, three, four or more of the different reference BM patterns / reference profiles depicted in Table 3 for predicting, identifying or classifying, from a subject's saliva sample the emotions or groups of emotions felt by the subject after being stimulated by a specific olfactory stimulus.
[0066] In another aspect, the present invention also relates to the use of a kit for predicting, assessing, or identifying emotions or groups of emotions felt by a subject under olfactory stimulation from a saliva sample, the kit comprising:
[0067] a) a device for collecting at least two saliva samples individually from the subject; and
[0068] b) A kit for measuring the amount / concentration of each of the following four molecular markers present in the saliva sample: α-amylase, cortisol, DHEA, and oxytocin; and
[0069] c) Optionally, the specification is for applying the method according to the invention (any one of claims 1 to 14), or includes at least one of each different reference BM mode / reference profile depicted in Table 3, preferably at least two, three, four or at least one reference BM mode / reference profile.
[0070] In another aspect, the present invention also relates to the use of a kit for assessing the ability of olfactory stimulation to evoke / remove a desired emotion or emotion group in a subject from a saliva sample, the kit comprising:
[0071] a) A device for collecting at least two saliva samples from the subject individually;
[0072] b) A kit for measuring the amount / concentration of each of the BMs present in the saliva sample, particularly the following four BMs present in the saliva sample: α-amylase, cortisol, DHEA, and oxytocin; and
[0073] c) Optionally, the specification, for applying the method according to the invention, or containing at least one of the reference saliva BM features depicted in Table 3, preferably at least two, three, four or at least one reference saliva BM feature.
[0074] In a preferred embodiment, the use of the kit according to the invention is characterized in that the measurement of the amount / concentration of each of the BMs present in the saliva sample is performed by standard analytical biochemical assays well known to those skilled in the art, such as, but not limited to, ELISA, LCMS or GCMS (liquid chromatography or gas chromatography-mass spectrometry), enzymatic assays, and encapsulated nanoparticle enzyme assays.
[0075] The inventors have also demonstrated that, through measurement Figure 1 At least three of the BMs listed herein, preferably four BMs, more preferably the four BMs (α-amylase, cortisol, DHEA, and oxytocin) present in the saliva sample after stimulation of the subject, are then combined in a specific combination according to a specific ratio (S2 / S1 ratio) of each BM, which can be:
[0076] - Identify the emotions or emotion groups felt by the subject; or
[0077] -Assess the ability of the test's stimuli to evoke / recall the desired emotion or group of emotions.
[0078] Each of these at least 3 BMs, preferably Figure 1 The four BMs listed herein, more preferably, are independently selected and can provide statistically significant information and improve the performance of the desired diagnosis, especially compared to a more limited combination of BMs, which is designed to achieve optimal performance with the fewest number of BMs.
[0079] Therefore, preferably, in the method of the present invention, the measured BMs can be combined with each other through a logic function. This logic function can include, for example, but is not limited to:
[0080] -Use direct measurements obtained for these BMs (isolated or simple measurements that have not been modified before being introduced into the logic function), or preferably,
[0081] - Report relative measurements of these BMs using indirect measurements obtained for these BMs, for example, with reference to the measurements of these BMs of the subject before stimulation.
[0082] For example, scores can be obtained through specific combinations of the selected BM. These specific combinations can be obtained, for example but not limited to, statistical methods of the type of binary logistic regression, wherein, for example:
[0083] - First, test potentially independent measurements of BM in univariate analysis; and
[0084] - Secondly, the inventors then tested the measurements of the four BMs that were identified as significant in the univariate analysis using binary logistic regression in a multivariate analysis. This logistic regression allows for the acquisition of specific analytical profiles or, for example, scoring formulas in the following form:
[0085] The score is calculated as follows: Score = a0 + a1.X1 + a2.X2 + a3.X3 + a4.X4, where coefficients a1 to a4 are constants, and variables X1 to X4 are values measured for each of the four BMs. This score allows for:
[0086] - Identify the emotions or emotion groups felt by the subject; or
[0087] -Assess whether the stimuli used in the test can evoke / elicit the desired emotion or desired emotion group.
[0088] Those skilled in the art who wish to use these specific analytical profiles, scores, or algorithms in the context of this invention will be able to identify them. Therefore, it is necessary to have a sufficient database, which specifically includes:
[0089] - Absolute or relative measurements of the four BMs identified by the inventors based on the tested stimuli; or
[0090] - A group of subjects who are known to experience the desired emotions or emotional groups sought in response to a given stimulus.
[0091] Preferably, the method according to the invention is characterized in that the stimulus is a sensory stimulus, and more preferably an olfactory stimulus.
[0092] Preferably, but not limitingly, the olfactory stimuli are selected from perfumes or fragrances or any compounds, materials, plants, or animals that can emit odors that may evoke emotions.
[0093] More preferably, the olfactory stimulus is fragrance or scent.
[0094] The term "perfume" or "fragrance" in this invention (these terms are used interchangeably) refers, but is not limited to, the naturally emitted scents of plants, animals, fungi, or the environment, or more commonly, to a more or less persistent, scented composition, or even consumer products (such as manufactured articles) intended for the end consumer. It may particularly include beauty, home, and hygiene products (creams, shampoos, laundry detergents, etc.). Fragrances can be used in the production of perfumes (premium fragrances) or consumer products. In nature, fragrances are typically chemical and biochemical messages, particularly pheromones or plant hormones.
[0095] The term perfume or fragrance, here also refers to any emitting substance made from natural materials (such as flower extracts) or reconstituted from various fragrances, solvents, and fixatives (substances produced by chemical processes), intended for cosmetic use or for adding scent to objects, animals, or indoor air. Perfumes can be made from plant extracts and / or synthetic molecules.
[0096] Perfume or fragrance is also understood to refer to a specific olfactory composition, which is generally pleasant and can be of varying concentrations. This composition may be offered in packaged form and may have different intensities of scent (for example, in cosmetics, this could include eau de cologne, eau de toilette, eau de parfum, or perfume, which are typically distinguished by the concentration of their natural oils or essential oils or the amount of active aromatic ingredients present in the product).
[0097] Therefore, perfumes or fragrances can be composed of different compounds, such as natural oils, alcohols, and water. The combination of these ingredients creates a specific perfume that can be personalized according to the user's preferences. Thus, perfumes or fragrances are often designed to reflect the user's personality while evoking positive emotions.
[0098] Perfumes or fragrances may also contain other ingredients, such as fixatives or solvents, which help prolong the lasting power of the perfume.
[0099] The term "perfume" or "fragrance" here also refers to any combination of several different aromatic substances that, when mixed, produce a unique fragrance.
[0100] Preferably, for each of the four BMs, the ratio between the measured amount / concentration of the substance present in the saliva sample obtained 1 to 30 minutes after stimulation, preferably 5 to 20 minutes, and the measured amount / concentration of the substance present in the saliva sample obtained approximately 1 to 30 minutes before stimulation, preferably 5 to 10 minutes, is calculated.
[0101] Furthermore, the method according to the invention is characterized in that, in step 3, before determining the amount / concentration of the BM, the saliva sample collected after and / or before stimulation is pre-frozen, preferably at a temperature less than or equal to 20°C.
[0102] Preferably, the method according to the invention is characterized in that the emotion or the group of emotions is selected from:
[0103] - The following emotions, but not limited to: emotional, comforting, relaxed, elegant, confident, engrossed, energetic, happy, specific (unique);
[0104] as well as
[0105] -The following groups of emotions, but not limited to: comfort and relaxation, elegance and sensuality.
[0106] Furthermore, the method according to the invention is characterized in that the measurement of the amount / concentration of the selected BM is performed using biochemical or spectroscopic measurements.
[0107] In another aspect, the present invention relates to a kit comprising:
[0108] a) A device for collecting saliva samples to measure each of four biomarkers (BMs) in the sample: α-amylase, cortisol, DHEA and optionally their derivatives, and oxytocin.
[0109] b) A kit for measuring the amount / concentration of each of the four BMs present in the saliva sample.
[0110] c) Instruction manual.
[0111] Preferably, the kit according to the invention is characterized in that the amount / concentration of each of the selected BMs present in the saliva sample is measured primarily by ELISA.
[0112] On the other hand, the present invention relates to the use of a kit according to the invention for assessing or identifying, from a subject’s saliva sample, the subject’s feelings or emotion groups after being stimulated.
[0113] In another aspect, the present invention relates to the use of a kit according to the invention for assessing the ability of a stimulus to evoke / recall / elicit a desired emotion or group of emotions in a subject from a saliva sample.
[0114] Preferably, for these uses according to the invention, the stimulus is an olfactory stimulus, and / or the emotion or the group of emotions is selected from:
[0115] - The following emotions, but not limited to: emotional, comforting, relaxed, elegant, confident, engrossed, energetic, happy, specific (unique);
[0116] as well as
[0117] -The following groups of emotions, but not limited to: comfort and relaxation, elegance and sensuality.
[0118] Although this disclosure and its advantages have been described in detail, it should be understood that various changes, substitutions, and modifications may be made herein without departing from the spirit and scope of this disclosure as defined by the appended claims. Furthermore, the scope of this application is not intended to be limited to the specific embodiments of the methods and steps described in the specification. Those skilled in the art will readily understand from this disclosure that, based on this disclosure, existing or future embodiments that perform substantially the same function or achieve substantially the same results as the corresponding embodiments described herein can be utilized. Attached Figure Description
[0119] Figure 1 Molecular biomarkers of mood
[0120] Figure 2 : Stability of BM under varying storage temperature over 48 hours.
[0121] Figure 3 Stability of BM studied over 7 days.
[0122] Figures 4.1A to 4.1D and Figure 4.2 Schematic diagram of the study on the diurnal rhythm variation of BM level.
[0123] Figures 5A to 5D Concentration of salivary biomarkers based on circadian rhythms.
[0124] Figure 6 : A schematic diagram summarizing changes in salivary biomarkers, expressed as a percentage compared to measurements taken at 9 a.m. (100%).
[0125] Figure 7 : A schematic representation of the sampling process.
[0126] Figures 8A to 8E : The kinetics of biomarker concentrations after exposure to fragrance.
[0127] Figure 9 A diagram illustrating the group process.
[0128] Figure 10 A to Figure 10 B: Correlation of variance.
[0129] Figures 11A to 11D and Figure 11A 'to Figure 11D Comparison of average concentrations of biomarkers measured under olfactory stimulation.
[0130] Figure 12A to Figure 12B : A representation of how the concentration of biomarkers measured under fragrance stimulation changes according to mood.
[0131] Figure 13 Examples of individual representations of the evolution of emotions and biomarkers.
[0132] Figure 14 Examples of individual expressions used to convey feelings of empathy and comfort.
[0133] Figures 15-1A to 15-1C and Figure 12-2: Individuals were divided into 6 groups based on their biomarker profiles using the K-mean.
[0134] Figure 16 Research design and objectives.
[0135] Figure 17 : Ratio association of salivary biomarkers.
[0136] Figure 18 Principal component analysis (PCA) of biomarker ratios (S2 / S1 and / or S3 / S1).
[0137] Figures 19A to 19C ANOVA analysis of the salivary BM ratio among different emotional valence groups (0 to 2) in the questionnaire.
[0138] Figure 20A to Figure 20D : Use stratified k-means (hk-means) based on the proportion profile of salivary biomarkers to nest participants together.
[0139] Figure 21 : Use stratified k-means (hk-means) based on the proportion profile of salivary biomarkers to nest participants together.
[0140] Figure 22A to Figure 22F : Proportion of salivary biomarker ratios for each cluster nested with HK mean for the total cohort (59 participants × 4 fragrances: 236 unique combinations) using the ratio S2 / S1 of biomarkers.
[0141] Figure 23 Temporal evolution of the ratios of individual saliva biomarkers (S1 / S1; S2 / S1; S3 / S1) in HK mean clustering of the total cohort (59 participants × 4 fragrances: 236 unique combinations) using the ratio S2 / S1 of the biomarkers.
[0142] Figure 24A to Figure 24F: Principal component analysis (PCA) was performed on discretized binary emotions (response 0 = negative response to a given emotion; responses 1 and 2 nested together = positive response to a given emotion) as quantitative variables and their correlation with different variables (B to G) was analyzed.
[0143] Figure 25 Clustering was performed using the saliva BM S2 / S1 ratio and data derived separately by fragrance, using the HK mean.
[0144] Figure 26 Different saliva BM profiles correspond to different emotional profiles.
[0145] Figure 27 Clusters formed by independent HK means performed individually for each fragrance shared saliva BM profiles and exhibited similar emotional response profiles.
[0146] Figure 28 Individual case study. Participant E-044.
[0147] Figure 29 Case study. Participant E-078.
[0148] Figure 30 Salivary oxytocin and α-amylase levels are related to evaluation
[0149] Figure 31 Discretization of the salivary biomarker ratio (S2 / S1) for a novel clustering method
[0150] Figure 32 Classification of the ratio of saliva biomarkers (S2 / S1) used for emotion recognition / prediction
[0151] Figure 33 Classification of the ratio (S2 / S1) of saliva biomarkers used for emotion recognition / prediction.
[0152] Figure 34 Overview of Fragrance-Induced Emotions Based on Implicit Testing Example
[0153] introduce
[0154] The purpose of this specification is to demonstrate the feasibility of detecting biomarkers of emotion from saliva samples. To confirm this feasibility, biochemical kits for measuring different biomarkers (α-amylase, cortisol, DHEA, and oxytocin) identified by the inventors in saliva were investigated and used. Different parameters related to the samples were also investigated and selected. Finally, different methods for detecting the characteristics were studied and satisfactory results were provided.
[0155] Example 1: Verification of Emotions
[0156] Identify the target emotion and conduct a literature search for the selected emotion.
[0157] Example 2: Selection of a reference kit for the determination of biomarkers in saliva
[0158] The results presented in the following examples not only confirm the presence of the four biomarkers identified by the inventors in saliva, but also confirm their association with mood. For each of the four biomarkers, different assay kits were tested. The technique used for some kits was ELISA. Several analytical performance criteria were examined, allowing for kit selection based on the biomarker. Recovery rates are used to illustrate performance. Recovery rate represents the kit's ability to detect a controlled increase in the biomarker in saliva.
[0159] These performance figures are from the commercial kit used in this first study. They are suitable for the proof-of-concept phase, but can certainly be improved.
[0160] Example 3: A method for discovering the biosignatures of emotions
[0161] The biomarker of emotion can be defined as a combination of one or more biomarkers that allow for significant identification of emotion. The discovery of this characteristic is carried out in two main phases. First, a preliminary examination is conducted to ensure the quality of the biomarker measurements. This phase is performed in a reduced cohort. Second, the characteristic is searched for using different methodological approaches. This phase is performed in the full cohort. These two phases are described below.
[0162] Preliminary verification phase
[0163] In the initial validation phase, different experimental parameters are tested to study their impact on the measurements and thus determine the final configuration of the tests.
[0164] a) Question: Do biomarker measurements provide usable information?
[0165] b) Validate the repeatability of biomarker measurements
[0166] c) Verify the stability of biomarkers in the sample over time.
[0167] d) Verify the impact of the environment on biomarker levels (circadian rhythm).
[0168] e) Validate the measurement parameters (time after exposure), and
[0169] f) Response: Reliable tests and protocols for feature discovery
[0170] At the end of this phase, various experimental parameters are established (measurement kits, ability to freeze samples if necessary, sampling time, and sampling cycle after exposure to fragrance).
[0171] Feature research stage
[0172] For the characterization phase, the cohort is exposed to the fragrance and must answer questionnaires relating to emotions or all other methods of assessing emotions known to those skilled in the art. Characterizing emotions means being able to separate two groups based on biometrics: the group that expresses emotions (respondents) and the group that does not express emotions (non-respondents).
[0173] The different stages of feature research will be described below:
[0174] a) Question: Are there any biological characteristics that can identify emotions?
[0175] b) Verify the independence of the four biomarkers through correlation studies.
[0176] c) Pre-select and understand the mechanism
[0177] -Independent of general trends in the entire population during questionnaire searches
[0178] - Searching for differences between responders and non-responders using biomarkers and expressed emotions.
[0179] - Search for biometrics based on sentiment profiles (based on 4 biomarkers)
[0180] d) Using advanced statistics to search for biometrics
[0181] In this context, the subjectivity of emotions and responses to the questionnaire further complicate the task. Therefore, nine emotions of interest were randomly selected in the context of olfactory stimulation. Furthermore, a large cohort is required for rigorous execution of this phase, which was not feasible at the level of this study. Therefore, the preferred approach when using advanced statistics consists of associating biomarkers with a consistent set of emotions. Advanced statistics highlighted the biomarker variation profiles specific to the “relaxation” emotion, as well as the “relaxation + solace” and “elegance + sensitivity” groups.
[0182] Example 4: Saliva Sample
[0183] During this study, several parameters of the saliva samples were validated. The saliva samples were confirmed to conform to current operating procedures in terms of group composition. Therefore, saliva samples were demonstrated to be usable as a tool, based on the four molecular markers identified by the inventors, for identifying subjects' moods or mood groups after olfactory stimulation, particularly during exposure to fragrances / perfumes.
[0184] Example 5: Selecting a reference kit for determining selected biomarkers
[0185] Objective: To determine a reference kit for measuring BM.
[0186] The measurement of molecular biomarkers in saliva can be biased by many physiological and technical factors. In this section, we specifically describe the research work that defined and validated reference kits for measuring DHEA (and its sulfated ester SDHEA) and OXT. These selections were based on analyses of two biochemical kits by mass spectrometry (BM). The kits, their performance, and their relevance as reference kits were evaluated.
[0187] method
[0188] We determined the selection of a reference kit for measuring biomarkers in saliva through three steps:
[0189] -Evaluate and compare two biochemical kits used to measure each BM in the supplier-recommended buffer.
[0190] - Evaluate two artificial saliva substrates (one with high fluidity and the other with high viscosity).
[0191] - Saliva samples from volunteer donors (n=6) were quantified. All saliva samples used to quantify each BM using these two kits were collected in the morning (before 10:00 AM), aliquoted, and stored at -80°C until use.
[0192] Definition of the reference test for alpha-cortisol
[0193] Cortisol (and its derivative corticosterone)
[0194] Knowledge related to cortisol
[0195] cortisol
[0196] Cortisol is a hormone, or glucocorticoid, produced from cholesterol in the adrenal cortex under the influence of adrenocorticotropic hormone (ACTH) secreted by the pituitary gland. Cortisol has various effects on the body. Among other effects, it promotes the catabolism of lipids and proteins, inhibits the action of insulin, and promotes glycogen production in the liver. It also has anti-inflammatory and anti-allergic effects, inhibiting the production of pro-inflammatory cytokines (such as IL-12, IFN-α, IFN-α, and TNF-α), and stimulating the release of serotonin and histamine through the upregulation of IL-4, IL-10, and IL-13 via Th2 cells.
[0197] Cortisol secretion is controlled by the hypothalamic-pituitary (HPA) axis through the action of ACTH and CRH (corticotropic hormone-releasing hormone).
[0198] Cortisol and mood
[0199] The limbic system, composed of the thalamus and amygdala, is the emotional center of the central nervous system and can trigger the HPA axis and release cortisol into the body based on emotions (6). In cases of depression or chronic stress, the HPA axis may be overactivated, causing persistent hypercortisolism, leading to a deterioration of mental state and significant metabolic disorders in individuals.
[0200] In the Trier Social Stress Test (TSST), individuals under acute stress and anxiety also showed elevated salivary cortisol levels.
[0201] A positive mental state can often mitigate the health effects of stressors. They likely function through the same metabolic pathways that allow stressors to exert their neuroendocrine effects.
[0202] Cortisol and Corticosterone
[0203] In saliva, cortisol degradation is associated with non-enzymatic reactions (hydrolysis, redox), bacterial metabolism (intracellular and extracellular enzymes), and endogenous metabolism of cortisol to corticosterone by the enzyme 11-β-hydroxysteroid dehydrogenase (11b-HSD). Storage of saliva samples at 4°C limits this degradation. Literature reports that cortisol levels remain stable for up to 5 days in human saliva samples stored at room temperature or 4°C (3).
[0204] Cortisol assay method
[0205] Salivary cortisol levels show a good correlation with their bioactive serum levels. Normal salivary cortisol levels range from 1 ng / mL to 11.3 ng / mL. Salivary cortisol is typically measured using enzyme-linked immunosorbent assay (ELISA). Other methods, such as liquid chromatography-mass spectrometry (LC-MS), can also be used. However, immunoassay remains the most common method due to its ease of use and high degree of automation.
[0206] Corticosterone detection and determination
[0207] Free cortisol diffuses into saliva, where it is rapidly converted into corticosterone by 11bHSD type 2 (11β-hydroxysteroid dehydrogenase) secreted by the salivary glands. Normal values for salivary corticosterone have not been determined, but studies suggest it varies between 10 ng / mL and 100 ng / mL. Salivary corticosterone is typically measured using enzyme-linked immunosorbent assays (ELISA). Other assays, such as LC-MS, are also available. However, immunoassay remains the most common and is advantageous due to its ease of use and high degree of automation. Corticosterone levels are 5 to 10 times higher than cortisol levels, and minute changes in salivary cortisol levels induced by olfactory stimulation are amplified in salivary corticosterone.
[0208] Definition of the gold standard for β-α-amylase
[0209] α-Amylase
[0210] Alpha-amylase is an enzyme found in pancreatic and salivary secretions that specifically hydrolyzes α(1→4) glycosidic bonds. It plays a crucial role in the digestion of starch into monosaccharides that are more easily absorbed by the body. The catalytic activity of amylase can be measured in several biofluids, including blood and saliva. Salivary α-amylase secretion increases during stress episodes and is also associated with norepinephrine release. Therefore, quantifying salivary α-amylase activity can indirectly assess the activity of two major nervous systems controlling stress: the hypothalamic-pituitary-adrenal (HPA) axis and the salivary nervous system (SNS). Thus, salivary amylase may represent a biomarker of interest for assessing certain psychophysiological states in humans.
[0211] In addition to its physiological association with emotional state, salivary α-amylase also exhibits good stability, making it suitable for sample collection and storage. In fact, saliva samples can be stored at room temperature for 4 days without losing activity and at -20°C for at least 6 months without losing activity. The effects of continuous freeze / thaw cycles are negligible below 5 cycles (7).
[0212] Used to measure saliva α -Amylase method
[0213] The measurement of α-amylase is primarily performed by measuring its enzyme activity. Several techniques and different definitions of enzyme units exist for this purpose. Monitoring α-amylase activity can be conducted using spectrophotometry, electrochemistry, potentiometric analysis, photochemical immobilization, etc. There are also methods that directly determine α-amylase concentration using immunofluorescence. Therefore, comparisons between methods are very difficult. Although there are no reference values for salivary α-amylase levels, one study estimated its activity to be approximately 100 U / mL to 200 U / mL.
[0214] Definition of the reference test for C-DHEA
[0215] DHEA related knowledge
[0216] DHEA
[0217] Dehydroepiandrosterone (DHEA) is a cholesterol-derived hormone primarily produced by the adrenal cortex under the influence of adrenocorticotropic hormone (ACTH) secreted by the pituitary gland. DHEA mainly circulates in the form of sulfated DHEA. DHEA is a circulating precursor to testosterone, estrogen, and progesterone. It is also involved in immune function and cellular senescence (1).
[0218] The concentration of DHEA in the body begins to rise around age 6 to 8 and continues to rise steadily. After age 30, the molecule declines in a quasi-linear manner with age, exhibiting a similar diurnal rhythm variation to that observed in cortisol. Serum DHEA concentrations vary with age and sex, ranging from 60 ng / mL to 9000 ng / mL. DHEA levels measured in blood and saliva are highly correlated, and salivary DHEA concentrations are not affected by enzymes or saliva turnover (2).
[0219] DHEA and Emotions
[0220] DHEA is also produced directly in the nervous system and functions as a neuroactive and neuroprotective factor. Its production increases when faced with acute psychosocial stress. Decreased DHEA concentrations are associated with deterioration in cognitive function and mood. Restoring blood DHEA concentrations in patients aged 40 to 70 years to levels comparable to those of younger adults resulted in significant improvements in their physical and mental health after 3 months: better sleep quality, better mood, more energy, and better stress management (4).
[0221] Multiple studies have also shown that this molecule has other protective effects on physical and mental health, muscle strength, bone density, fat mass, skin elasticity, and allergies.
[0222] DHEA measurement methods and results
[0223] Like salivary cortisol, DHEA is also present in saliva and can be measured using enzyme-linked immunosorbent assay (ELISA). Other methods, such as liquid chromatography-mass spectrometry (LC-MS), are also available. However, immunoassay remains the most common method due to its simplicity and high degree of automation.
[0224] Definition of the reference test for D-oxytocin
[0225] OXT related knowledge
[0226] Oxytocin
[0227] Oxytocin (OXT) is a nine-amino acid neuropeptide primarily produced in the hypothalamus. It participates in many physiological processes and plays an important role in childbirth and lactation (5). It is also involved in socio-emotional processes and reproduction. OXT exerts its effects not only locally in the central nervous system (CNS) but also systemically in multiple organs. The action of OXT is mediated by binding to its receptor, which is primarily expressed in the mammary gland, uterus, and CNS. Oxytocin is degraded by a variety of aminopeptidases (oxytocinases) expressed in different cell types.
[0228] Oxytocin and Mood
[0229] Oxytocin regulates the integration of emotional information and interacts with reward pathways. In the brain, OXT acts as a neurohormone or neuromodulator. It is released during positive social interactions and can downregulate stress, heart rate, and blood pressure.
[0230] OXT released from the posterior pituitary gland is considered the primary source of salivary OXT. Therefore, neuropeptides primarily synthesized in the CNS, such as OXT, can serve as indirect indicators of brain function and are thus more likely to be directly related to mood.
[0231] OXT Measurement Method
[0232] The standard analytical techniques for quantifying oxytocin are radioimmunoassay, enzyme-linked immunosorbent assay (ELISA), and liquid chromatography-mass spectrometry (LC-MS).
[0233] Oxytocin is a difficult molecule to measure. There is currently no reference value for salivary oxytocin because there is no validated and standardized test. To date, the most widely used method is enzyme-linked immunosorbent assay (ELISA). Several studies have involved sample pretreatment steps (centrifugation, column extraction, etc.); however, these methods…
[0234] This can lead to a significant, measurable loss of oxytocin. Finally, proteolytic enzymes present in saliva can break down peptides, such as oxytocin.
[0235] B – Study on the stability of biomarkers with changes in temperature and storage time
[0236] Study on BM stability at different temperatures for 48 hours
[0237] We evaluated the stability of salivary biomarkers under different preservation and storage conditions. First, saliva samples (N=4) were stored for 48 hours at different temperatures (-20°C, 4°C, room temperature, 37°C, 42°C, and 60°C). The concentrations or enzyme activities of the four MBs were quantified on the day of collection (D0) to determine reference values (100%), and then quantified again at 48 hours (see [link to relevant documentation]). Figure 2 ).
[0238] Figure 2 : Stability of BM under varying storage temperature over 48 hours.
[0239] Results represent the average of the measured values of BM in saliva samples (N=4). Results are expressed as a percentage relative to the concentration measured at D0 (which represents 100%). Measurements at D0 were performed on fresh saliva. Average CV is expressed as bars. RT: room temperature.
[0240] Cortisol and DHEA remained stable after 48 hours of storage at temperatures ranging from -20°C to 42°C, reaching levels comparable to D0. α-Amylase was stable at -20°C and 4°C with no detected loss of activity. Storage at room temperature resulted in a significant reduction in measured activity, and at higher temperatures, its activity could not be quantified. For oxytocin, all tested storage temperatures appeared to affect its stability. Storage at -20°C and 4°C resulted in a loss of at least 26% in its measured concentration. For the other temperatures studied, oxytocin could not be quantified after 48 hours of storage. Storage at 60°C prevented quantification of the four biomarkers studied. Conclusion: For the remainder of the stability studies, the storage temperatures selected for the different biomarkers were: -20°C for oxytocin, +4°C for α-amylase, and room temperature (RT=21°C) for DHEA and cortisol.
[0241] Stability study of BM within one week
[0242] Based on previous data, we evaluated the effect of storing saliva samples at a defined temperature for 7 days on the stability of each biomarker (BM). The storage temperature chosen for each biomarker was such that, above this temperature, the BM would lose its stability, thus reducing its assay efficiency. Experiments were also conducted on four saliva samples (see [link to experiment]). Figure 3 ).
[0243] Figure 3 Stability of BM studied over 7 days.
[0244] Results represent the average of the measured values of BM in saliva samples (N=4). Results are expressed as a percentage relative to the concentration measured at D0 (which represents 100%). Measurements at D0 were performed on fresh saliva. Average CV is expressed as bars. RT: room temperature.
[0245] All BMs showed satisfactory stability in saliva over 7 days. The observed changes were on the same order of magnitude (+ / -20%) as those observed during the robustness study. Surprisingly, oxytocin showed significant stability at -20°C over 7 days, with increased concentrations detected on days 2, 3, and 7.
[0246] Conclusion: All results indicate that BM remains stable in saliva for at least 7 days, provided that the predetermined storage temperature for each BM is adhered to. This temperature is 4°C for α-amylase, room temperature (RT) for cortisol and DHEA, and -20°C for oxytocin.
[0247] Study on the temporal changes of endogenous levels of C-biomarkers
[0248] a) Distribution of baseline levels of salivary biomarkers.
[0249] (See Figures 4.1A to 4.1D)
[0250] Figures 4.1A to 4.1D: Distribution of baseline levels of salivary biomarkers.
[0251] Saliva biomarkers ((A) α-amylase-AA; (B) cortisol-CORT; (C) The distribution of basal levels (S1) of DHEA (and (D) oxytocin-OXT) showed significant inter-individual variability (AA = 79.1 ± 57 (U / mL, mean ± SD), 268.1 (maximum), 12.2 (minimum); CORT = 2559.2 ± 1534.6 (pg / mL, mean ± SD), 10825.2 (maximum), 562.12 (minimum); DHEA = 745.3 ± 460.3 (pg / mL, mean ± SD), 2467.2 (maximum), 55.1 (minimum); OXT = 96.1 ± 75.1 (pg / mL, mean ± SD), 406.5 (maximum), 14.7 (minimum). The lowest amplitude observed for cortisol was 19.2 times (maximum / minimum), and the highest amplitude for DHEA was 44.8 times (maximum / minimum). Basal levels were analyzed using S1 sampling prior to olfactory stimulation.
[0252] b) Studies on salivary biomarker levels based on circadian rhythms and day cycles .
[0253] (See) Figure 4.2 )
[0254] The objective of this study was to assess the impact of diurnal variability on the endogenous levels of salivary biomarkers under investigation. Intra-individual and inter-individual variations were evaluated in eight donors. For this purpose, saliva samples were collected at three times of the same day (9:00 AM, 12:00 PM, and 3:00 PM) and over three consecutive days (see [link to study]). Figure 4.2 ).
[0255] Figure 4.2 : A schematic diagram illustrating the intraday variation of BM levels. Eight individuals were analyzed at three different times (9:00 AM, 12:00 PM, and 3:00 PM) over three consecutive days (D1: Day 1; D2: Day 2; and D3: Day 3).
[0256] result :
[0257] The results of time-varying changes in salivary biomarker levels are presented in Figures 4.1A to 4.1C and Figure 4.2 In general, intraday variations are more significant than interday variations, and these follow the data already described in the literature.
[0258] Figures 5A to 5D Concentration of salivary biomarkers based on circadian rhythms.
[0259] Box plots representing the quantitative BM concentrations in eight saliva samples collected at three different times (9:00 AM, 12:00 PM, and 3:00 PM) over three consecutive days (D1 to D3). A: Salivary α-amylase activity (U / mL); B: Salivary cortisol concentration (ng / mL); C: Salivary DHEA concentration (pg / mL); D: Salivary oxytocin concentration (pg / mL). D1: Day 1; D2: Day 2; and D3: Day 3. The median is represented by a line, and the mean by a cross.
[0260] α-Amylase
[0261] In the eight volunteers studied, α-amylase activity increased throughout the day ( Figure 5A The median value (measured over 3 days) at 9 AM was 70 U / mL, at 12 PM it was approximately 90 U / mL, and at 3 PM it was 133 U / mL. We observed inter-individual variability, with less significant variability in samples collected at 9 AM and 12 PM compared to those collected at 3 PM. In fact, the distribution of individual data was more dispersed at 3 PM. These results were comparable across the 3 days of the experiment.
[0262] Cortisol and DHEA
[0263] The concentrations of salivary cortisol and DHEA also vary throughout the day, but in the opposite direction to those of α-amylase. Figure 5B and Figure 5C These two molecules tend to decrease between early morning (9 a.m.) and mid-afternoon (3 p.m.). The concentrations of cortisol and DHEA are highest at 9 a.m., at which time greater inter-individual variability is observed in the population. Then, a sharp decrease in concentration is measured at noon, and a less significant decrease is measured at 3 p.m. These results are reproduced over the three days of the experiment.
[0264] Oxytocin
[0265] The concentration of salivary oxytocin appears to decrease very slightly throughout the day. Figure 5D High intra- and inter-individual variability was observed. The concentration range for the same individual (different dates, same time) was 28 pg / mL to 129 pg / mL, while the concentration range between two individuals at the same time on the same day was 38 pg / mL to 1167 pg / mL. Analysis of data from the same day revealed a gradual decrease in salivary oxytocin throughout the day (between 9 am and 3 pm).
[0266] Figure 6 : A schematic diagram summarizing changes in salivary biomarkers, expressed as a percentage compared to measurements taken at 9 a.m. (100%).
[0267] Each point represents the average value obtained from measurements taken over 3 days at each time point in the study.
[0268] In the context of this group study, considering the following factors, collecting saliva samples in the morning is preferred:
[0269] • For the three biomarkers (cortisol, DHEA, and oxytocin), the median value at 9 a.m. was in the middle of the standard range of the reference kit.
[0270] The median average at 9 a.m.:
[0271] ○ Cortisol: 1830 pg / mL; Kit range: 50 pg / mL to 3200 pg / mL.
[0272] ○DHEA: 505.21 pg / mL; Kit range: 20 pg / mL to 2160 pg / mL.
[0273] ○ Oxytocin: 183.31 pg / mL; Kit range: 15.6 pg / mL to 1000 pg / mL.
[0274] At 12 noon and 3 pm, the obtained concentrations were close to the lower end of the standard range. If olfactory stimulation caused a significant decrease in these BMs, we were unable to quantify them because the levels would be at the lower limit of quantitation of the kit.
[0275] • The concentration of α-amylase varies between 10% and 20% in the morning (between 9 a.m. and 12 p.m.), but can vary by up to +80% between 12 p.m. and 3 p.m. This dramatic variation in the middle of the day may bias the measurement results of this BM during olfactory stimulation studies, in which multiple samples will be collected over a period of 30 minutes to 1 hour.
[0276] • Samples collected in the morning can be processed and analyzed on the same day. This is not the case if samples are collected after 2 PM, due to technical and logistical reasons. In fact, the reference kit required for oxytocin assays requires overnight incubation, which prolongs the storage time of the samples before assay (in this case, the samples will be measured more than 30 hours after collection).
[0277] In summary, circadian rhythms influence salivary levels of the biomarkers studied. Saliva concentrations of cortisol and DHEA decrease throughout the day. Conversely, measured α-amylase activity increases more significantly after noon. Salivary oxytocin levels appear less affected by circadian rhythms, but their concentration decreases moderately throughout the day. All these results are consistent with data in the literature. The envisioned group test will have a duration of approximately 30 minutes. The changes in biomarkers observed in the morning between 9 a.m. and noon within 30 minutes are sufficiently low (approximately 6%) to be suitable for analysis during group periods.
[0278] D – Preparation of group conditions: Kinetics of biomarker measurement after aromatherapy stimulation (preparatory group)
[0279] A preliminary group consisting of a small number of volunteers was organized. This preliminary group had two main objectives:
[0280] -Assess logistical aspects: Utilize a reduced queue to organize the group, allowing for validation and planning of the group's progress in accordance with research objectives.
[0281] - Evaluate the kinetics of biomarkers following olfactory stimulation. Perform a kinetic study following stimulation and collect samples at different time points after stimulation. This allows for the determination of the optimal time to collect saliva samples after stimulation (see [link to study]). Figure 7 )
[0282] Figure 7 : A schematic representation of the sampling process.
[0283] S1 to S5: Sampling 1 to Sampling 5; FT1 to FT5: Fragrance time 1 to Fragrance time 5.
[0284] For the preparatory group, participants were gathered at two different time slots in the morning, either 9:00 AM (n=2) or 10:00 AM (n=3), to undergo olfactory stimulation testing. Figure 7 The fragrance provided by MANE and used for the preparatory group was the same as that for the future group (number 267). Samples were collected before stimulation (S1, 5 minutes before stimulation). Four samples were collected after stimulation at short (5 and 15 minutes) and long (30 and 60 minutes) intervals (S2 to S5). Kinetic results are shown in... Figure 7 middle.
[0285] Figures 8A to 8E : The kinetics of biomarker concentrations after exposure to fragrance.
[0286] Participants (C and D) were notified to participate in the test at 9:00 AM (n=2), and participants (A, B, and E) were notified to participate in the test at 10:00 AM (n=3). Samples were collected 5 minutes before the stimulus (T1) and 4 samples (T2 through T5) were collected after the stimulus (5 minutes; 15 minutes; 30 minutes; 1 hour). The ratio represents the ratio of the reported measurements of T2, T3, T4, and T5 to the measurement of T1. The stimulus is indicated by a vertical red dashed line.
[0287] Kinetic assessment of biomarker measurements following olfactory stimulation showed that:
[0288] • Olfactory stimulation does produce significant changes in salivary biomarkers related to mood, and this occurs within minutes of stimulation.
[0289] • The results for changes in the amount or activity of BM after olfactory stimulation were comparable in people convened at 9 a.m. and 10 a.m.
[0290] • We selected two short time points, 5 minutes and 20 minutes after stimulation, to measure these 4 BMs during the group period.
[0291] Our primary aim is to measure the quantitative changes or activity of olfactory stimuli on the target BM, rather than to restore it to a baseline state of variable duration.
[0292] E-POC group: Conducts studies on multiple subjects, thus allowing for preliminary statistical analysis.
[0293] After completing the preparatory group, we organized a full-scale group of 30 participants to measure four target biomarkers to validate the concept.
[0294] The following were studied:
[0295] -Measure the response of saliva BM to olfactory stimulation by fragrance (provided by MANE on a solid support) and carrier (unfragrant solid support provided by MANE).
[0296] - The study involved multiple participants, allowing for preliminary statistical analysis. - Individual testing was conducted on four target BMs.
[0297] Regulatory Authorization for Research Involving Humans (RIPH)
[0298] This study is a Type 3 RIPH study involving humans, corresponding to a non-interventional study, which poses no risk or limitation to humans. To conduct this study on humans, we created a management document that includes:
[0299] - The study was registered on the ANSM (French Agency for the Safety of Medicines and Health Products) website to obtain a national RCB (Research and Biodepository Center) number. Therefore, the study has the number 2022-A02008-35.
[0300] - The CNRS Data Protection Division conducted a personal data impact analysis, which compiled:
[0301] • Provide a systematic description of the proposed processing operations and objectives, including, where applicable, the legitimate interests pursued by the data controller;
[0302] • Assess the necessity and proportionality of the processing actions relative to the objective;
[0303] • Assess the risks to the rights and freedoms of those involved;
[0304] • Measures envisioned to address these risks include guarantees, measures, and safeguards designed to ensure that personal data is protected and that compliance with regulatory requirements is demonstrated.
[0305] - A self-declaration regarding compliance with CNIL (French National Commission for Information Technology and Civil Liberties) regulations. This declaration states that the laboratory's data processing strictly adheres to the MR-003 reference method. This is a self-declaration and was made on September 26, 2022 (CNIL reference: 2227634 v 0).
[0306] - Submit a document to the CPP (Committee on the Protection of Persons) with comments of approval.
[0307] Group organization
[0308] The goal is to develop a methodology and sampling scheme that meets both scientific and technological constraints and is acceptable to the team members.
[0309] Given that several stressors unrelated to the test itself might arise in the initial stages, we chose to investigate the effects of carrier stimulation (fragrant support). Therefore, a total of two olfactory stimuli were evaluated during this group: fragrant stimuli (number 267) and carrier stimulation (number 943).
[0310] A total of 30 subjects were tested. Each subject's participation was spread over two days: day 1 included carrier stimulation, day 2 included aromatherapy stimulation, or vice versa. This is equivalent to testing 60 subjects.
[0311] The selected fragrances have been evaluated; questionnaire results are now available. Selected support material: glass jars of air freshener beads.
[0312] The group was organized for 4 days (15 subjects per day, using only one type of stimulus).
[0313] Invited participants attended a regulatory information session about the project. After signing a study participation consent form, each participant entered a room for testing. Three saliva samples were collected: the first sample was collected 5 minutes before stimulation (S1), the second sample was collected 5 minutes after stimulation (S2), and the third sample was collected 20 minutes after stimulation (S3).
[0314] Store the sample at +4°C until the time of experimental analysis.
[0315] All subjects underwent testing with two stimuli over two days. All biomarkers could also be measured on all samples (see [link to relevant documentation]). Figure 9 ).
[0316] Figure 9 A diagram illustrating the group's procedures.
[0317] Sampling S1 to S3: Sampling 1 to Sampling 3; FT1 to FT3: Fragrance time 1 to Fragrance time 3. CT1 to CT3: Carrier time 1 to Carrier time 3.
[0318] Conclusion: Therefore, saliva samples are suitable for groups using olfactory stimulation. For the purposes of this study, one sample was collected before olfactory stimulation and two samples were collected after olfactory stimulation.
[0319] F - Analysis of BM's response to olfactory stimuli
[0320] The four BMs were measured according to the previously defined scheme.
[0321] Each measurement was performed in triplicate. Data collected in the form of concentration or enzyme activity were supervised by two individuals. For each BM, the concentration for each individual was determined under fragrance and carrier stimulation conditions. All data were analyzed using statistical tests appropriate for this type of data.
[0322] Before the analysis, several steps were taken to ensure that the data followed a normal distribution:
[0323] - Use the Shapiro test to ensure that the transformed measurements follow a normal distribution. - Use the Box-Cox transformation to transform the measurements so that their distribution approximates a normal distribution.
[0324] Overall analysis of correlation
[0325] The first analysis investigated the correlation between data obtained from four molecular markers after fragrance or carrier stimulation. Figure 10 A to Figure 10 B).
[0326] Figure 10 A to Figure 10 B: Correlation of variance.
[0327] T1: Data collected 5 minutes before stimulation; T2: Data collected 5 minutes after stimulation; T3: Data collected 20 minutes after stimulation. Color scales indicate the degree of correlation between two measurements: 1 = maximum correlation; -1 = maximum negative correlation. The Spearman method was used to calculate the correlation.
[0328] The dark blue diagonal lines indicate a predicted strong correlation between measurements of the same biomarker before and after olfactory stimulation across the three samples (T1, T2, T3).
[0329] During aromatherapy stimulation, cortisol and DHEA data obtained at all study time points showed a weak correlation. This was also observed during stimulation using a carrier, but to a lesser extent. This corroborates data from the literature describing similar (but not identical) changes in salivary cortisol and DHEA.
[0330] After fragrance stimulation, the measured values of α-amylase were inversely correlated with the measured values of cortisol and also showed a milder inverse correlation with the measured values of DHEA. This inverse correlation was not observed with carrier stimulation.
[0331] Oxytocin is not related to other BM.
[0332] In summary, a weak correlation was observed between cortisol and DHEA measurements after stimulation with fragrance or carrier. Only under fragrance stimulation did α-amylase measurements show an inverse correlation with cortisol and DHEA measurements. Oxytocin provided distinctly different information from other biomarkers. These results were observed at three measurement times (T1, T2, and T3). All these results indicate that the correlation varies with the type of olfactory stimulation and are consistent with existing data in the literature. This observation suggests that preserving these four biomarkers is important for characterization.
[0333] Global analysis of changes in biomarkers after olfactory stimulation
[0334] Data for each BM and each stimulus were then analyzed at the group level under study. Paired Student's t-tests were used to compare transition measures between T1 (before stimulus), T2 (5 minutes after stimulus), and T3 (20 minutes after stimulus) (see [link to study]). Figures 11A to 11D and Figure 11A 'to Figure 11D (and Table 1).
[0335] Figures 11A to 11D and Figure 11A 'to Figure 11D Comparison of mean biomarker concentrations measured under olfactory stimulation. Each graph represents one biomarker: α-amylase (A, A'), cortisol (B, B'), DHEA (C, C'), and oxytocin (D, D'). For each biomarker, measurements were transformed using a Box-Cox transformation with different λ values for each biomarker (0.35 for α-amylase, 0.13 for cortisol, 0.23 for DHEA, and -0.15 for oxytocin). Each graph shows the data distribution at each time point (T1 = 5 minutes before stimulation, T2 = 5 minutes after stimulation, T3 = 20 minutes after stimulation), with representations of quantiles, mean (points), median (lines), and p-values obtained by comparing the means of different samples (T1, T2, and T3) using a paired Student's t-test. Ns: p>0.05; *: p<=0.05; **: p<=0.01; ***: p<=0.001; ****: p<=0.0001.
[0336] The overall distribution of biomarker measurements in the entire population (N=30) studied in the group varies depending on the sampling time and the stimulus (fragrance or carrier).
[0337] Table 1 summarizes all p-values obtained during comparisons at three time points (T1, T2, and T3) when the same BM and the same stimulus were studied.
[0338] In the presence of fragrance, the mean values of α-amylase, cortisol, and DHEA showed highly significant changes in at least two comparisons. This was not the case for carrier stimuli other than cortisol.
[0339]
[0340] Table 1: Comparison of average concentrations of each BM as expressed by p-values.
[0341] Paired Student's t-test was used to compare the means among the three time points T1, T2, and T3. Comparisons highlighted in gray have a p-value < 0.01. T: Sample collection time (T1, T2, and T3).
[0342] Conclusion: These results indicate that while significant differences exist depending on the stimulus, group-level analysis remains important at this level. A sample size of N=30 may result in insufficient statistical power. Furthermore, individual perceptions may differ, leading to variations in biological responses. Therefore, subgroup or even individual analyses were employed in the remainder of the proof-of-concept study, establishing a systematic link with participants' reported emotions.
[0343] Global analysis of BM changes related to emotion
[0344] Group participants answered a questionnaire developed in collaboration with MANE immediately after olfactory stimulation. Subjects were able to answer 10 questions 5 minutes after continuous olfactory stimulation and before T2 saliva samples were collected.
[0345] Responses to emotion-related questions were discretized: the questionnaire included questions related to nine emotion categories: immersion, elegance, confidence, happiness, vitality, uniqueness, sensitivity, comfort, and relaxation. For each emotion, there were potentially five responses. Reactions considered negative or neutral (“completely disagree,” “somewhat disagree,” and “neither agree nor disagree”) were categorized as “false.” Reactions “somewhat agree” and “completely agree” were categorized as “true.”
[0346] Participants' responses to each emotion were discretized according to the terms "true" and "false". All analyses of changes in biomarkers for each discretized emotion are represented by box plots. For each discretized emotion ("false" or "true"), the results obtained by measuring biomarkers varied depending on the aroma or carrier stimulus.
[0347] It should be noted that the vast majority of responses to emotions are quite negative (“false”). No single emotion elicits a majority of positive responses (“true”) regardless of the stimulus. For the carrier, there are 7 emotions (out of a total of 9), of which the number of “false” emotions is greater than 24 individuals. Therefore, for the carrier, it is difficult to analyze the responses of BMs related to emotions.
[0348] For fragrances, three types of emotions can be defined based on the number of "genuine" responses:
[0349] 1- Approximately 50% of genuine responses: Relaxed, comforted, and emotional. 2- Approximately 35% of genuine responses: Elegant, energetic, and joyful. 3- Approximately 20% of genuine responses: Enchanted, confident, and unique.
[0350] During aromatherapy stimulation, the average concentration of BM varied across different study time points for the four emotions of "immersion, comfort, relaxation, and uniqueness" (Figure 12A). The evolution of biomarkers at time points T2 and T3 may differ. This suggests that changes in biomarkers over time may depend on the emotion experienced after stimulation. For example, we observed that the AA biomarker corresponding to the emotion of "energetic" changed rapidly after stimulation (T2 / T1), while the DHEA biomarker corresponding to the emotion of "happy" changed later (T3 / T2). Figure 12B ).
[0351] Figure 12A to Figure 12B : The representation of how the concentration of biomarkers measured under fragrance stimulation changes with mood.
[0352] As an example, four emotions are represented. A) BM changes regardless of the time ratio studied; B) BM changes very rapidly after stimulation (T2 / T1) or later (T3 / T2). Each point represents a single saliva sample. These ratios are calculated based on raw values of BM concentration. Each graph shows the data distribution for the three ratios studied (T2 / T1, T3 / T1, and T3 / T2), with quantiles, mean (points), and median (lines). False: A response considered negative or neutral in terms of emotion; True: A response considered positive in terms of emotion.
[0353] Conclusion: Olfactory stimuli elicit different biomarker changes over time. Different olfactory stimuli (e.g., fragrances or carriers) lead to different biomarker changes.
[0354] Individual analysis of changes in emotion-related biomarkers
[0355] The data collected during the group session allowed us to analyze individual biological responses to olfactory stimulation and compare them with expressed emotions.
[0356] For each individual (N=30) and the olfactory stimulation administered, we have 9 emotional indications (rated from 1 to 5) and measurements of 4 biomarkers over time.
[0357] These data are represented separately ( Figure 13 ).
[0358] Figure 13 Examples of individual representations of the evolution of emotions and biomarkers.
[0359] The numbers E-0XX correspond to the subjects participating in the study. E-016 and E-024 have biomarker profiles with minimal variation. E-004, E-007, E-017, and E-026 present biomarker profiles with more significant changes after olfactory stimulation.
[0360] It can be noted that for 15 out of 30 subjects (E001, E003, E005, E008, E012, E013, E014, E015, E016, E018, E020, E021, E024, E09, E030), responses to nine emotions following carrier stimulation were systematically expressed in a negative manner (rating 1) or neutral (rating 3) (Appendix). This was never observed with aromatherapy stimulation. However, changes in biomarker concentrations were observed in some of them.
[0361] We observed that, following olfactory stimulation, the biomarker profiles of some individuals (e.g., E016, E024) did not change or changed very little with the intensity of emotional feelings. Figure 13 Conversely, from the perspective of biomarkers and questionnaires, several individuals (e.g., E007, E017, E026, E030, etc.) showed very strong responses. This suggests that some people are more sensitive to olfactory stimuli than others. This is interesting because it allows us to identify individuals who are more or less sensitive to olfactory stimuli (a phenomenon common with many sensory stimuli). Individual responses to emotional stimuli and the profiles of biological responses vary considerably. However, certain emotions (e.g., feeling touched or comforted) appear to correspond to specific biomarker profiles (…). Figure 13 For example, for the emotion of "emotionality," the biomarker profile appears to correspond to: α-amylase initially decreasing and then increasing between T1 and T2, followed by T2 and T3, while cortisol and / or DHEA continue to decrease after olfactory stimulation. For "comfort," α-amylase decreases, and oxytocin also appears to decrease after stimulation (T2 / T1), followed by an increase (T3 / T1).
[0362] Figure 14 Examples of individual expressions used to convey feelings of empathy and comfort.
[0363] "Emotional" and "comfortable" emotions are represented by radar charts, rated from 1 to 5. For "emotional," subjects E-004, E-017, E-019, and E-011 showed similar BM change profiles, and for "comfortable," subjects E-011, E-013, E-027, and E-007 showed similar BM change profiles.
[0364] Conclusion: Individual analyses of changes in emotion-focused biomarkers suggest that certain emotions appear to produce specific biomarker profiles. Similarly, these data suggest the potential for future assessments of an individual's sensitivity to olfactory stimuli. This preliminary study, based on a biomarker profile-focused classification, requires further analysis.
[0365] Individuals are categorized based on their biomarker profiles following olfactory stimulation.
[0366] K-means classification analysis of individuals based on their biomarker profiles ( Figure 14 We use K-means partitioning to separate individuals within a group based solely on biomarker measurements taken at different times. The principle behind this method is based on an algorithm that starts with k points (centroids) located in the space of our data (biomarker measurements). Each centroid is associated with its nearest individual, thus forming a group. Several algorithms can be applied to this method; in our case, we used the Hartingan-Wong algorithm. The results given below are obtained by partitioning our individuals into k=6 groups.
[0367] The goal was to objectify the initial observations obtained during individual analyses (as certain emotions may correspond to specific biomarker profiles). Furthermore, we have reserved the possibility of associating emotion groups with these profiles. The selection of these six groups was particularly relevant to the sample size (30 participants), ensuring that each group was large enough while maintaining an acceptable level of detail.
[0368] Figures 15-1A to 15-1C and Figure 15-2 Individuals were divided into 6 groups based on their biomarker profiles using the K-mean.
[0369] Figure 1 A to Figure 1 C: Overall representation of the analysis.
[0370] (A) Number of individuals in each group. (B) Percentage of individuals in each group who experienced each emotion. (C) Biomarker profiles in each group represented by different colors.
[0371] Each curve represents the mean and standard error of BM concentration for individuals in that group. 2) Biomarker profiles for each individual in groups 2, 4, and 5.
[0372] Six profiles were identified (Figure 15-1). Groups 2, 4, and 5 were studied more specifically due to their larger size (other groups had four or fewer participants, which was considered insufficient to draw conclusions). Most participants in these groups responded to one or two emotions. Group 5 primarily highlighted “emotional” and “graceful” emotions (75% and 62%, respectively), while Group 4 highlighted “comfortable” and “relaxed” emotions. Group 2 very clearly indicated “relaxed” (80%). The profiles of change in each biomarker after stimulation differed for groups 2, 4, and 5. Figure 15-2 ).
[0373] Conclusion: Specific analysis of biomarker profiles in groups 2, 4, and 5 suggests the potential to identify biomarker profiles associated with the experienced emotion or emotion group.
[0374] Group's overall conclusion
[0375] In summary, this study has demonstrated that, as part of a panel and in a non-medical setting, four biological biomarkers associated with emotional responses can be measured in saliva within a reduced sampling time (<30 minutes).
[0376] Our research shows that olfactory stimulation induces changes in salivary biomarkers. These two different stimuli produce different salivary biomarker responses.
[0377] Individual measurements of BM following olfactory stimulation can be performed simultaneously with classic questionnaires on emotion.
[0378] Preliminary statistical analysis shows that:
[0379] - Emotions can produce specific biomarker profiles in saliva, and this occurs within minutes of olfactory stimulation.
[0380] Measuring BM in saliva allows us to capture the diversity of group responses to olfactory stimuli in a highly sensitive and objective manner.
[0381] The number of individuals tested in this preliminary study (N=30) made it possible to identify trends, but these trends must be tested in a larger-scale study (the current EMJOY study plans to have N=120 individuals).
[0382] - It can assess a person's sensitivity to olfactory stimuli; that is, a person who systematically produces strong or weak responses to olfactory stimuli.
[0383] Example 6: Saliva Sample
[0384] In this study, to reduce experimental bias caused by the sampling environment, we developed a saliva sampling protocol for individuals participating in the olfactory testing group outside the laboratory.
[0385] plan :
[0386] 1- Saliva samples should preferably be collected while seated, and the patient should rest for 5 to 10 minutes before collection.
[0387] 2. Samples should preferably be collected 15 minutes after the last beverage consumption, meal, smoking / e-cigarette use, candy consumption, chewing gum, brushing teeth, or rinsing mouth.
[0388] 3. Do not cough or clear your throat (to avoid mixing in phlegm), but let the saliva flow out on its own; spit out the required amount of saliva, making sure it is liquid and not foam.
[0389] 4. Samples must be collected in suitable sterile test tubes, preferably washed with a virucidal / bactericidal agent after collection, and then immediately placed at +4°C.
[0390] 5. The person being sampled must not have symptoms or signs of active oral inflammation, advanced periodontitis or severe gingivitis, nor should they have a confirmed or suspected chronic infectious disease.
[0391] 6. Preferably, at least two saliva samples should be collected, one before stimulation and one after stimulation.
[0392] Example 7: Research Design and Objectives
[0393] (See) Figure 16 )
[0394] Research Design and Objectives .
[0395] a) Group research
[0396] For the group study, a questionnaire was used to collect participants' emotions during olfactory stimulation. In this questionnaire, emotions were defined semantically using specific words corresponding to six emotions to be assessed. Emotional responses were discretized into two categories: negative responses, corresponding to responses with no emotion / no emotion felt towards the fragrance; and positive responses, grouping responses to the fragrance from strong to moderate. We then investigated the relationship between changes in four biomarkers and the emotional responses collected in the questionnaire. Global and individual analyses were performed. These analyses enabled us to define a biomarker-based profile of fragrance-induced emotions.
[0397] Example 8: Ratio Correlation of Saliva Biomarkers .
[0398] (See) Figure 17 )
[0399] Reliable measurements of four biomarkers (AA, Cort, DHEA, OXT) were performed on 708 saliva samples (including 236 unique participant / fragrance combinations and three sampling time points (1, 2, and 3) for each combination) (mean coefficient of variation <9%). Weak or no correlations were observed among BMs (between DHEA and cortisol), indicating that each biomarker varied independently and confirming the importance and individual contribution of each BM to the molecular characteristics of mood.
[0400] Example 9: Principal component analysis (PCA) of biomarker ratios (S2 / S1 and / or S3 / S1)
[0401] (See) Figure 18 )
[0402] Principal component analysis (PCA) was performed on the biomarker ratios (S2 / S1 and / or S3 / S1). PCA was conducted using datasets of all participants who had smelled the four scents, or on a scent-by-scent-analysis basis. No pattern distribution was observed for any of the emotions analyzed. PCA analysis of the BM ratios did not allow for the interpretation of individual emotions.
[0403] Example 10: ANOVA analysis of salivary BM ratios among different emotional valence groups (0 to 2) in the questionnaire. .
[0404] (See) Figures 19A to 19C )
[0405] ANOVA analysis of salivary biomarker ratios among different emotional valence groups (0 to 2) in the questionnaire. Biomarker ratios were compared among groups responding to different emotional valence levels. ANOVA analyses were performed on the entire cohort (59 participants × 4 scents = 236 unique combinations) using each emotion individually or all six emotions together as continuous or discrete variables. The results in the figure above are examples of biomarker ratios that could be predicted in discrete ANOVA analysis using all six emotions together when all scents were considered. A: DHEA S3 / S1 ratio for "comfort" emotion; B: DHEA S3 / S1 ratio for "energetic" emotion; and C: DHEA S2 / S1 ratio for "comfort" emotion. The table shows the significant p-values (p < 0.1) for each emotion and its corresponding biomarker ratio.
[0406] Example 11: Using stratified k-means (hk-means) to profile participants based on the proportion of salivary biomarkers Nested together .
[0407] (See) Figure 20A to Figure 20D )
[0408] This method allows 1) to compute hierarchical clusters, 2) to cut the tree into k clusters, 3) to compute the center (i.e., the mean) of each cluster, 4) to perform k-means by using the set of cluster centers (defined in step 3) as the initial cluster centers, and 5) to optimize the clusters.
[0409] This means that the final optimized partition obtained at step 4 may differ from the initial partition obtained at step 2. We performed k-means and hk-means using either 8 BM ratios (4 BMs × 2 sampling ratios S2 / S1 and S3 / S1) or 4 BM ratios (4 BMs using only the S2 / S1 sampling ratio). We also performed hk-means with different thresholds for the stratification step to obtain different nested architectures. Furthermore, we applied hk-means clustering to the groups formed by the previous hk-means, performing sub-clustering.
[0410] Examples of some HK means performed individually for each fragrance using the biomarker ratio S2 / S1 are: (A) Fragrance J3, which is nested into five clusters consisting of 21, 22, 7, 9 and 1 individuals respectively; (B) Fragrance J4, which is nested into four clusters consisting of 16, 25, 16 and 2 individuals respectively; (C) Fragrance J5, which is nested into five clusters consisting of 24, 24, 4, 3 and 4 individuals respectively; and (D) Fragrance J6, which is nested into four clusters consisting of 28, 25, 3 and 3 individuals respectively.
[0411] Example 12: Using stratified k-means (hk-means) to profile participants based on the proportion of salivary biomarkers Nested together
[0412] (See) Figure 21 )
[0413] This method allows 1) calculating hierarchical clusters, 2) cutting the tree into k clusters, 3) calculating the center (i.e., the mean) of each cluster, 4) performing k-means by using the cluster center set (defined in step 3) as the initial cluster centers, and 5) optimizing the clusters.
[0414] This means that the final optimized partition obtained at step 4 may differ from the initial partition obtained at step 2. This example illustrates HK-means clustering of the total cohort (59 participants × 4 fragrances: 236 unique combinations) using a biomarker ratio of 2 / 1. Participants were nested into five clusters consisting of 69, 46, 18, 95, and 8 individuals.
[0415] Example 13: Using the ratio S2-S1 of biomarkers to the total cohort (59 participants × 4 fragrances: 236 fragrances) A profile of the ratios of salivary biomarkers in each cluster of the unique combination of HK means nested.
[0416] (See) Figure 22A to Figure 22F )
[0417] The spider plot shows the absolute ratios for each cluster (A: Cluster 1 – 69 individuals; B: Cluster 2 – 46 individuals; C: Cluster 3 – 18 individuals; D: Cluster 4 – 95 individuals; and E: Cluster 5 – 8 individuals). The violin plot compares the distribution of biomarker ratios (S2 / S1) between groups. Light blue: Cluster 1; green: Cluster 2; purple: Cluster 3; orange: Cluster 4; and dark blue: Cluster 5.
[0418] Example 14: Using the ratio S2 / S1 of biomarkers to the total cohort (59 participants × 4 fragrances: 236 fragrances) Temporal evolution of the ratios (S1 / S1; S2 / S1; S3 / S1) of individual salivary biomarkers in HK mean clustering (unique combination)
[0419] (See) Figure 23 )
[0420] The curves represent the ratios of individual biomarkers in different samples (S1, S2, and S3), which have been normalized based on the S1 biomarker concentration for each participant. The curves are colored by fragrance, and the mean of each cluster is represented by a thick black line. The standard deviation is represented by a black dashed line.
[0421] Example 15: Questionnaire-based sentiment profiling in HK Means Clustering
[0422] (See Table 2):
[0423]
[0424] Table 2: Questionnaire-based mood profiles in HK mean clustering. Chi-square tests were used to assess differences in mood responses between groups formed by HK means across the entire cohort (236 unique combinations of participants / fragrances) or by fragrance alone. Data for p-values are shown in this table. Mood responses were discretized (questionnaire response O = negative response to a given mood; nested questionnaire responses 1 and 2 = positive response to a given mood).
[0425] Example 16: Discretized binary emotions (Questionnaire response 0 = negative reaction to a given emotion; Questionnaire response 1 = negative reaction to a given emotion). Principal component analysis (PCA) was performed on the positive response to a given emotion (nested together with 2), using it as a quantitative variable, and then... Analyze the correlation with different variables (B to G). .
[0426] (See) Figure 24A to Figure 24G )
[0427] (A) This figure illustrates PCA using data from the entire cohort (236 unique combinations). Using all data from all participants who smelled the four fragrances, the projected clusters were nested by performing HK-means clustering. No pattern distribution was observed for any of the variables analyzed: (B) HK-means cluster groups; (C) rating; (D) intensity; (E) Same as (B), but with some random effects added to visually demonstrate the existence of multiple measures with the same coordinates due to the limited number of variables (6 emotions) and only two possible values (0; 1). Larger points correspond to the true values; smaller points are randomly distributed around their actual values); (F) fragrance; (G) gender. Similar analyses were also performed using HK-means clustering performed separately for each fragrance.
[0428] Example 17: Using saliva BM S2 / S1 ratio and data derived separately for each fragrance, the mean was calculated using HK. Clustering
[0429] (See) Figure 25 )
[0430] For each fragrance (J3 to J6) and each cluster, the graph shows the emotional response profile in the left column as a radar chart (data expressed as a percentage of participants who responded out of the total number of individuals nested in each cluster); in the middle and right columns, the log2 of the average BM ratio profile (S2 / S1) is shown as a histogram (middle) or a spider chart (right), respectively.
[0431] Example 18: Different salivary BM profiles correspond to different emotional profiles
[0432] (See) Figure 26 )
[0433] Clusters were formed using the BM S2 / S1 ratio and data derived separately for each fragrance, using the HK mean. Four clusters (G1 to G4) were formed using data from fragrance J6. For each cluster, the graph shows an overview of emotional responses as a radar chart on the left (data expressed as a percentage of participants responding out of the total number of individuals nested within each cluster). In the middle and right, the log2 of the average BM ratio (S2 / S1) is shown as a histogram (middle) or a spider plot (right), respectively.
[0434] Clusters were categorized as follows: G3 was characterized by very low confidence; G3 by high happiness, relaxation, comfort, and confidence, and low vitality and sensitivity; and G4 by high happiness, relaxation, vitality, and confidence, and low comfort. A cluster was considered highly responsive to a given emotion when more than 66% of participants in each cluster responded positively to the emotion; moderately responsive when >33% to <66% of participants in each cluster responded positively to the emotion; and lowly responsive when less than 33% of participants in each cluster responded positively to the emotion. Each cluster, nested using only the BM ratio (S2 / S1) data, exhibited a unique profile of emotional response: G1 was predominantly characterized by high happiness, moderate relaxation, comfort, and low vitality, confidence, and sensitivity; and G2 by high happiness, relaxation, comfort, moderate vitality, and sensitivity.
[0435] Example 19: Sharing saliva BM profiles among clusters formed by independent hk means performed individually for each fragrance, and Furthermore, they exhibit similar emotional response profiles.
[0436] (See) Figure 27 )
[0437] Clusters were formed using the BM S2 / S1 ratio and data derived separately for each fragrance, with the HK mean. The graph shows cluster 2 (G2) (J5G2) formed using data from fragrance J5; cluster 2 (G2) (J6G2) formed using data from fragrance J6; cluster 2 (G2) (J3G2) formed using data from fragrance J3; and cluster 2 (J4G2) formed using data from fragrance J4. For each cluster, the graph shows an overview of emotional responses as a radar chart on the left (data expressed as a percentage of participants responding out of the total number of individuals nested within each cluster). In the middle and right, the log2 of the average BM ratio (S2 / S1) is shown as a histogram (middle) or a spider plot (right), respectively. A cluster is considered highly responsive to a given emotion when more than 66% of participants in each cluster respond positively to the emotion; a cluster is considered moderately responsive to a given emotion when >33% to 66% of participants in each cluster respond positively to the emotion; and a cluster is considered poorly responsive to a given emotion when less than 33% of participants in each cluster respond positively to the emotion.
[0438] Clusters J5G2 and J6G2 showed similar BM profiles (slightly decreased / stable α-amylase, cortisol, and DHEA levels, while oxytocin levels were increased), and very similar emotional response profiles (J5G2 showed high happiness, moderate relaxation, comfort, and energy, and low self-confidence and emotionality, while J6G2 showed high happiness and relaxation, moderate comfort, energy, and emotionality, and low self-confidence).
[0439] Example 20: Individual Case Study .
[0440] A) Participant E-044
[0441] (See) Figure 28 )
[0442] The ratio of salivary biomarkers (S2 / S1) was associated with specific emotional profiles at the individual level. After smelling aromatherapy products J3 and J4, participant E-044 exhibited the same biomarker ratio profile (low decrease / stable α-amylase levels, high decrease in cortisol and DHEA levels, and low increase / stable oxytocin levels). This biomarker ratio profile was associated with a lack of emotional responsiveness. Furthermore, when the same participant was stimulated by aromatherapy products J5 and J6, the participant exhibited the following biomarker ratio profile: a high decrease in α-amylase levels and a moderate / high increase in cortisol, DHEA, and oxytocin levels. In this case, the aromatherapy triggered emotional responses associated with moderate happiness and high levels of comfort and relaxation.
[0443] Clusters J3G2 and J4G2 showed similar BM profiles (significantly decreased levels of α-amylase, cortisol, and DHEA, while oxytocin levels decreased slightly / remained stable), and very similar emotional response profiles (J3G2 showed high happiness and energy, moderate confidence, and low levels of relaxation, comfort, and sentimentality, while J6G2 showed high happiness and energy, moderate relaxation and comfort, and low levels of confidence and sentimentality).
[0444] B) Participant E-078
[0445] (See) Figure 29 )
[0446] The ratio of salivary biomarkers (S2 / S1) was associated with specific mood profiles at the individual level. After smelling aromatherapy J3 and J5, participants E-078 exhibited similar biomarker profiles (for J3, α-amylase levels were slightly elevated / stable, cortisol and DHEA levels were moderately / highly elevated, and oxytocin levels were slightly / moderately decreased; for J5, α-amylase levels were slightly / moderately decreased, cortisol and DHEA levels were moderately / highly elevated, and oxytocin levels were slightly / moderately decreased). These biomarker profiles were associated with a mood response of high relaxation and moderate happiness and confidence. After exposure to aromatherapy J4 and J6, participants exhibited similar biomarker profiles, showing a moderate to high decrease in α-amylase and oxytocin levels, while cortisol and DHEA levels remained stable to moderately decreased. This biomarker ratio was associated with happiness and relaxation in J4 and happiness, relaxation, and confidence in J6.
[0447] The conclusions of Examples 18 to 20 (see...) Figures 26 to 29 )
[0448] Following olfactory stimulation, the ratios of salivary biomarkers (S2 / S1 and S3 / S1) were used to cluster individual participants based solely on their biomarker profiles. Clustering was performed using the biomarker ratios as either continuous variables (hk mean, CART) or discrete variables (CART). We then analyzed the profiles of emotional responses within each cluster.
[0449] In HK mean clustering (with BM as a continuous variable), different salivary BM profiles correspond to different emotional profiles (see [link to relevant documentation]). Figure 26 In this context, each cluster, nested using only the BM ratio (S2 / S1) data, exhibits a unique profile of emotional response: G1 is predominantly high happiness, moderate relaxation, comfort, and low energy, confidence, and sentimentality; G2 is high happiness, relaxation and comfort, moderate energy and sentimentality, and low confidence; G3 is high happiness, relaxation, comfort and confidence, and low energy and sentimentality; and G4 is high happiness, relaxation, energy and confidence, and low comfort and sentimentality. Furthermore, salivary BM profiles are shared among clusters formed using independent hk means performed separately for each fragrance (see [link to relevant documentation]). Figure 27 In this context, they also exhibit similar emotional response profiles. For example, clusters J5G2 and J6G2 show similar BM profiles (slightly decreased / stable α-amylase, cortisol, and DHEA levels, while oxytocin levels are increased), and very similar emotional response profiles (J5G2 is highly happy, moderately relaxed, comforted, and energetic, and slightly confident and sentimental, while J6G2 is highly happy and relaxed, moderately comforted, energetic, and sentimental, and slightly confident).
[0450] Clusters J3G2 and J4G2 showed similar BM profiles (significantly decreased levels of α-amylase, cortisol, and DHEA, while oxytocin levels decreased slightly / remained stable), and very similar emotional response profiles (J3G2 showed high happiness and energy, moderate confidence, and low levels of relaxation, comfort, and sentimentality, while J6G2 showed high happiness and energy, moderate relaxation and comfort, and low levels of confidence and sentimentality).
[0451] At the individual level, associations were also found between emotional responses and salivary biomarker profiles (see [link to study]). Figure 28 and Figure 29For example, (1) after smelling fragrances J3 and J4, participant E-044 exhibited the same biomarker ratio profile (low decrease / stable α-amylase levels, high decrease in cortisol and DHEA levels, and low increase / stable oxytocin levels). This biomarker ratio profile was associated with a lack of emotional responsiveness. Furthermore, when the same participant was stimulated by fragrances J5 and J6, the participant exhibited the following biomarker ratio profile: a high decrease in α-amylase levels and a moderate / high increase in cortisol, DHEA, and oxytocin levels. In this case, the fragrances triggered emotional responses associated with moderate happiness and high levels of comfort and relaxation. (2) After olfactory stimulation with aromas J3 and J5, participants E-078 exhibited similar biomarker profiles (for J3, α-amylase levels were slightly elevated / stable, cortisol and DHEA levels were moderately / highly elevated, and oxytocin levels were slightly / moderately decreased; for J5, α-amylase levels were slightly / moderately decreased, cortisol and DHEA levels were moderately / highly elevated, and oxytocin levels were slightly / moderately decreased). These biomarker profiles were associated with a mood response of high relaxation and moderate happiness and confidence. After stimulation with aromas J4 and J6, participants exhibited similar biomarker profiles, showing moderate to high decreases in α-amylase and oxytocin levels, while cortisol and DHEA levels remained stable to moderately decreased. This biomarker ratio profile was associated with happiness and relaxation associated with J4 and happiness, relaxation, and confidence associated with J6.
[0452] Example 21: Correlation between salivary oxytocin and α-amylase levels and evaluation .
[0453] (See) Figure 30 )
[0454] The α-amylase / oxytocin ratio (S2 / S1) level was correlated with participants' ratings of the fragrances (the rating parameter was assessed across all fragrances). Participants who answered 5 or 6 (low rating) had a lower mean α-amylase (AA) ratio compared to participants who answered 3 or 4 (moderate rating) and 1 or 2 (high rating) on the fragrance rating questionnaire. Conversely, participants who answered 5 / 6 had a higher oxytocin ratio compared to participants who answered 3 / 4 or 1 / 2 on the fragrance rating questionnaire. This analysis was conducted using data from the entire cohort (236 unique participant / fragrance combinations).
[0455] Example 22: Discretization of the salivary biomarker ratio (S2 / S1) for a novel clustering method .
[0456] (See) Figure 31 )
[0457] To attempt to optimize the signal-to-noise ratio of biomarker ratios within clusters (as observed in clusters formed by k-means or hk-means - see Figure "Temporal evolution of individual salivary biomarker ratios (S1 / S1; S2 / S1; S3 / S1) in hk-means clusters"), Figure 23 We discretized the biomarker ratio (S2 / S1) by considering the average coefficient of variation (approximately 10%). The biomarker ratio was discretized into three categories (i.e., <0.9 = decrease; ≥0.9≤1.1 = stable; and >1.1 = increase). Based on this method, by combining the discretized biomarker ratios, 236 unique participant / fragrance combinations could be classified into 81 presupposed categories (e.g., Category 1 = decrease in α-amylase, decrease in cortisol, decrease in DHEA, decrease in oxytocin; Category 2 = decrease in α-amylase, decrease in cortisol, decrease in DHEA, increase in oxytocin, etc.).
[0458] Example 23: Classification of Saliva Biomarker Ratio (S2 / S1) Profiles for Emotion Recognition / Prediction
[0459] A) For those with vibrant emotions
[0460] (See) Figure 32 )
[0461] We use the Classification and Regression Tree (CART) algorithm to classify biomarker ratio profiles for positive or negative responses to the assessed emotions. The CART method uses the biomarker ratio S2 / S1 as a continuous or discrete variable. Using this method, participants are classified into leaves that have a positive (green) or negative (blue) response to a given emotion. This classification is based on the biomarker ratio (S2 / S1) profile. The numbers and information inside the leaves are explained in the upper right corner of the figure. An example of using discrete variables for CART on active emotions is given. Analyzing the green leaves that respond positively to an emotion allows for the identification of biomarker ratio profile patterns corresponding to the given emotion (lower left corner). Conversely, analyzing the blue leaves that respond negatively to an emotion allows for the identification of discrete biomarker ratio profiles corresponding to the absence of a given emotion (lower left corner).
[0462] B) Emotions of happiness, confidence, comfort, and relaxation .
[0463] (See) Figure 33 )
[0464] Classification of the ratio (S2 / S1) of saliva biomarkers used for emotion recognition / prediction.
[0465] We used the Classification and Regression Tree (CART) algorithm to classify the biomarker ratio (S2 / S1) profiles when the assessed emotions responded positively or negatively. Examples of decision trees generated by CART for emotions such as happiness, confidence, comfort, and relaxation are shown. The CART method was performed using the entire cohort data (236 unique individual / fragrance combinations) and the biomarker ratio S2 / S1 as discrete variables.
[0466] Example 24: Overview of Fragrance-Induced Emotions Based on Implicit Testing .
[0467] (See) Figure 34 )
[0468] Implicit testing was conducted on 80 volunteers in a separate cohort who smelled the same scents (J3, J4, J5, and J6) used to develop our biomarker-based mood profiles. Two parameters were measured implicitly: the GO / NO GO percentage (the number of participants who validated the mood associated with each scent) and the association strength (the speed of response to the mood associated with each scent). The GO / NO GO percentage was represented by angles (the mood was presented 3 times during the test, and % represents the number of clicks for each mood). Association strength (click speed) was represented by size and color. A higher association was considered when participants gave a quick response. Dark green: Excellent (>80th percentile, mood shown in bold); Green: Good (>50th percentile); Gray: Low (<50th percentile).
[0469] This implicit test allows for the definition of a mood profile for each of the four fragrances studied.
[0470] Scent-induced mood profiles based on molecular biomarkers and implicit tests were compared. The scent-induced mood profiles determined by the BM model were similar to those of implicit association tests.
[0471] This study was a cross-sectional assessment involving 59 participants. Each participant smelled four different fragrances (one fragrance per day of participation; these fragrances are hereinafter referred to as J3, J4, J5, and J6), and the smelling order was randomized. Participation included 1) sitting and resting for 5 minutes before the first saliva sample collection (5 minutes before the olfactory stimulation), and 2) smelling the fragrances and responding to a questionnaire.
[0472] in conclusion :
[0473] Saliva biomarker patterns for emotion prediction / identification. Identifying patterns of biomarker ratios (S2 / S1) corresponding to some identified emotions (happiness, confidence, comfort, and relaxation). Patterns were identified based on a decision tree generated using CART on the entire cohort data (236 unique individual / fragrance combinations) and the biomarker ratios S2 / S1 as discrete variables.
[0474] Example 25: Performance of Saliva Biomarker Patterns for Emotion Prediction / Recognition
[0475] (See Table 3)
[0476]
[0477] Table 3
[0478] Table 3: Saliva biomarker patterns used for emotion prediction / identification. Patterns were identified based on biomarker ratios (S2 / S1) corresponding to some identified emotions (happiness, confidence, comfort, and relaxation). Patterns were identified using a decision tree generated from the entire cohort data (236 unique individual / fragrance combinations) and the biomarker ratios S2 / S1 as discrete variables.
[0479] Example 26: Overview of Fragrance-Induced Mood Based on Biomarkers
[0480] (See Table 4)
[0481] Scent-Induced Emotional Profiles Based on Biomarkers. Emotional profiles for the scents tested in the cohort (J3, J4, J5, and J6) were identified using patterns based on saliva biomarkers associated with emotional responses. The emotional response for each biomarker-based scent corresponds to the percentage of participants who presented the identified biomarker-based emotional profile out of the total number of participants who smelled a given scent. The patterns used in this method were identified based on a decision tree generated using CART on the entire cohort data (236 unique individual / scent combinations) and the biomarker ratio S2 / S1 as a discrete variable.
[0482]
[0483] Table 4: Overview of Fragrance-Induced Mood Based on Biomarkers
[0484] Example 27: Performance of Prediction Accuracy
[0485]
[0486] Table 5: Performance of saliva biomarker patterns for emotion prediction / recognition.
[0487] We used biomarker patterns to identify participants' emotions, considering only the discrete biomarker ratio (S2 / S1) profile of the participants, and then compared biomarker-based emotional responses with questionnaire-based emotional responses. For each emotion, we calculated the sensitivity ("true" positive / total positive %) and specificity ("true" negative / total negative %) of a given emotion. The patterns used in this method were identified based on a decision tree generated using CART with the entire cohort data (236 unique individual / fragrance combinations) and the biomarker ratio S2 / S1 as a discrete variable.
[0488] in conclusion
[0489] We performed reliable measurements of 4 BM (AA, Cort, DHEA, OXT) on 732 saliva samples (including 244 unique participant / fragrance combinations and 3 sampling time points for each combination) (mean cv <9%).
[0490] No or weak correlation was observed among the business molecules (BMs), confirming the importance and individual contribution of each BM to the working window (WS).
[0491] We used data from 59 participants (236 unique participant / fragrance combinations) who smelled all four test fragrances to develop methods (including but not limited to PCA, k-means, hk-means, CART, etc.) to identify biomarker-based patterns associated with emotional responses.
[0492] Data from participants included measured biomarkers (AA, CORT, DHEA, OXT), primarily their relative measures (a 2:1 sampling ratio; or a 3:1 sampling ratio; or a combination of 2:1 and 3:1 sampling ratios). Biomarker ratios could be used as continuous or discrete variables.
[0493] Fragrances trigger Business Model (BM) responses, and participants can be categorized based on their BM profiles.
[0494] Different BM profiles correspond to different emotional profiles.
[0495] Some BM profiles are shared by different fragrances, and they correspond to similar mood profiles.
[0496] OXT and AA levels are related to the appreciation / evaluation of fragrances.
[0497] Discretization of the BM ratio allows for better classification of BM profiles.
[0498] Different BM profile patterns are associated with positive and negative emotional experiences.
[0499] Different BM models can be used for sentiment prediction.
[0500] The fragrance mood profile determined by the BM model is similar to an implicit association test.
[0501] in conclusion
[0502] This invention not only highlights the universality and feasibility of saliva sampling but also identifies biomolecular features (BM features) that allow for the differentiation of emotions. The prospects opened up by this invention for the precise identification of emotions through salivary biomarker features are very encouraging. According to this invention, it is also possible to identify profiles of individuals who produce strong or weak biological responses to olfactory stimuli. This perspective may pave the way for methods of selecting group members or clients based on biometrics.
[0503] bibliography
[0504] 1. Buford TW, Willoughby DS. Impact of DHEA(S) and cortisol on immune function in aging: a brief review. Appl Physiol Nutr Metab. 2008;33(3):429-33.
[0505] 2. Vining RF, McGinley RA. The measurement of hormones in saliva: possibilities and pitfalls. J Steroid Biochem. 1987;27(1-3):81-94.
[0506] 3. Liu Y, Papadopoulos V. BIOSYNTHESIS AND REGULATION OFDEHYDROEPIANDROSTERONE (DHEA) IN BRAIN. Endocrinologia molecular. 2005:135-45.
[0507] 4.Morales AJ, Nolan JJ, Nelson JC, Yen SS. Effects of replacementdose of dehydroepiandrosterone in men and women of advancing age. J ClinEndocrinol Metab. 1994;78(6):1360-7.
[0508] 5. McCormack SE, Blevins JE, Lawson EA. Metabolic Effects of Oxytocin.Endocr Rev. 2020;41(2)。
[0509] 6. Poisson B. A systemic biopsychological perspective on basic emotions. Mental Health in Quebec. 2016;40(3):223-44.
[0510] 7. Granger DA, Kivlighan KT, el-Sheikh M, Gordis EB, Stroud LR. Salivary alpha-amylase in biobehavioral research: recent developments and applications. Ann NY Acad Sci. 2007;1098:122-44。
Claims
1. A method for measuring the amount and / or concentration of salivary biomarkers (BMs) in a subject stimulated by an olfactory stimulus, wherein the salivary BMs are selected from the group consisting of: - Phenylalanine, tyrosine, tryptophan, levodopa, dopamine, norepinephrine, epinephrine, acetylcholine, cortisol, oxytocin, 5-HT, melatonin, substance P, chromogranin A, DHEA, DHEA sulfate, ghrelin precursor, α-amylase, BDNF, NPY and peptide YY, prostaglandins, endorphins and immunoglobulins, and wherein the method comprises the following steps: 1) Collect the subject’s first saliva sample (referred to as SI) prior to the stimulation; 2) Stimulate the subject with the olfactory stimulus; 3) Collect at least a second saliva sample (referred to as S2); 4) Measure the amount and / or concentration of each of the BMs present in the SI and S2 saliva samples; 5) Calculate the BM ratio (referred to as S2 / S1) for each selected BM.
2. The method of claim 1, wherein the amount and / or concentration of each of the following BMs are measured: α-amylase, cortisol, dehydroepiandrosterone (DHEA), and oxytocin.
3. The method according to any one of claims 1 and 2, wherein the saliva samples S1 and S2 are collected at any time of day, preferably between 9:00 a.m. and 12:00 p.m.
4. The method according to any one of claims 1 to 3, wherein the ratio value S2 / S1 calculated for each of the BMs in step 4) is a continuous variable or a discretized variable, preferably a discretized variable.
5. A method for determining salivary BM features in relation to the subject and a given olfactory stimulus from a saliva sample of a given subject, wherein the method includes the following steps: A) By using the method according to any one of claims 1 to 4, measuring and calculating the BM ratio S2 / S1 for each of the selected BMs, step A) ultimately determines the profile of these 4 BMs in relation to the stimulus and the subject; as well as B) Based on the results obtained in step A), determine the salivary BM characteristics associated with the stimulus and the subject.
6. A method for identifying / determining reference features associated with an emotion / emotional response and / or emotion group and / or fragrance and / or fragrance group felt by the subject after receiving an olfactory stimulus, the method comprising the steps of: C) Measure and calculate the BM ratio S2 / S1 for each of the selected BMs by the method according to claim 5; D) Repeat step C) for all subjects / individuals in a statistically significant cohort / group, using the same stimulus, and identify / determine the reference features associated with the said emotion and / or emotion group and / or fragrance and / or fragrance group using standard statistical methods.
7. The method according to claim 6, wherein step D) is performed on the different groups obtained after the queue / group is divided using a standard partitioning statistical method, thereby allowing the identification or determination of reference characteristics of each of these different groups, preferably k-means, hk-means (stratified k-means) statistical classification method.
8. The method according to any one of claims 5 to 7, wherein the emotion / emotional response and / or emotion group and / or fragrance and / or fragrance group perceived by the subject after olfactory stimulation is selected from the group consisting of: indulgent, elegant, confident, happy, energetic, unique, sensual, comforting and relaxing emotions / emotional responses, or combinations thereof.
9. The method according to any one of claims 5 to 8, wherein the individual measurement of the BM ratio is performed simultaneously with a questionnaire on the emotions felt by the subject after the olfactory stimulation.
10. The method of any one of claims 5 to 9, wherein the method comprises performing a latent test on the statistically significant cohort of subjects, the subjects smelling the same fragrance or fragrance group used to develop the biomarker-based mood profile.
11. A method for predicting, identifying, or classifying, from a saliva sample of a subject, the emotion or group of emotions felt by the subject after being stimulated by an olfactory stimulus, the method comprising the steps of: E) By the method according to any one of claims 1 to 5, measure and calculate the BM ratio S2 / S1 of each of the selected BMs in the saliva sample of the subject, and finally determine the salivary BM characteristics of the four BMs under the stimulation. F) Compare the saliva features obtained in step E) with reference saliva features obtained for these four BMs, the reference saliva features being identified as being associated with emotions or emotion groups; and G) Based on this comparison, predict, identify, or classify the emotion or group of emotions felt by the subject after being stimulated by the olfactory stimulus.
12. A method for determining the ability of an olfactory stimulus to evoke / remove a desired emotion or group of emotions in a subject from a saliva sample, the method comprising the steps of: H) By measuring and calculating the BM ratio S2 / S1 for each of the selected BMs using the method described in any one of claims 1 to 5, the salivary BM characteristics associated with the stimulus are ultimately determined; I) Identify reference saliva BM features associated with the emotion or group of emotions expected to be evoked / elicited after olfactory stimulation, said reference features being obtained by the method according to claim 6. J) Compare the saliva BM features obtained in step H) with the reference BM features identified in step I); as well as K) Based on this comparison, determine whether the stimulus of the test can evoke / elicit the desired emotion or emotion group.
13. The use of at least one of the reference saliva BM features described in Table 3 for predicting, identifying or classifying the emotions or groups of emotions felt by the subject after being stimulated by a specific olfactory stimulus from a saliva sample.
14. A kit for predicting, assessing, or identifying said emotion or emotion group felt by said subject in response to olfactory stimulation from a saliva sample, said kit comprising: a) a device for collecting at least two saliva samples individually from the subject; and b) A kit for measuring the amount / concentration of each of the following four molecular markers present in the saliva sample: α-amylase, cortisol, DHEA, and oxytocin; and c) Optionally, the specification is for applying the method according to any one of claims 1 to 12, or contains at least one of the reference saliva characteristics depicted in Table 3.
15. The kit is used to assess the ability of olfactory stimulation to evoke / induce a desired emotion or emotion group in a subject from a saliva sample, the kit comprising: a) A device for collecting at least two saliva samples from the subject individually; b) A kit for measuring the amount / concentration of each of the BMs present in the saliva sample, particularly the following four BMs present in the saliva sample: α-amylase, cortisol, DHEA, and oxytocin; and c) Optionally, the specification is for applying the method according to any one of claims 1 to 12, or containing at least one of the reference saliva BM characteristics depicted in Table 3.
